false 2025 Q2 0000898293 08/31 http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent 366 354 829 393 xbrli:shares iso4217:USD iso4217:USD xbrli:shares iso4217:CNY jbl:segment xbrli:pure jbl:year jbl:country 0000898293 2024-09-01 2025-02-28 0000898293 2025-04-03 0000898293 2025-02-28 0000898293 2024-08-31 0000898293 2024-12-01 2025-02-28 0000898293 2023-12-01 2024-02-29 0000898293 2023-09-01 2024-02-29 0000898293 2024-11-30 0000898293 2023-11-30 0000898293 2023-08-31 0000898293 us-gaap:CommonStockMember 2025-02-28 0000898293 us-gaap:CommonStockMember 2024-02-29 0000898293 us-gaap:AdditionalPaidInCapitalMember 2024-11-30 0000898293 us-gaap:AdditionalPaidInCapitalMember 2023-11-30 0000898293 us-gaap:AdditionalPaidInCapitalMember 2024-08-31 0000898293 us-gaap:AdditionalPaidInCapitalMember 2023-08-31 0000898293 us-gaap:AdditionalPaidInCapitalMember 2024-12-01 2025-02-28 0000898293 us-gaap:AdditionalPaidInCapitalMember 2023-12-01 2024-02-29 0000898293 us-gaap:AdditionalPaidInCapitalMember 2024-09-01 2025-02-28 0000898293 us-gaap:AdditionalPaidInCapitalMember 2023-09-01 2024-02-29 0000898293 us-gaap:AdditionalPaidInCapitalMember 2025-02-28 0000898293 us-gaap:AdditionalPaidInCapitalMember 2024-02-29 0000898293 us-gaap:RetainedEarningsMember 2024-11-30 0000898293 us-gaap:RetainedEarningsMember 2023-11-30 0000898293 us-gaap:RetainedEarningsMember 2024-08-31 0000898293 us-gaap:RetainedEarningsMember 2023-08-31 0000898293 us-gaap:RetainedEarningsMember 2024-12-01 2025-02-28 0000898293 us-gaap:RetainedEarningsMember 2023-12-01 2024-02-29 0000898293 us-gaap:RetainedEarningsMember 2024-09-01 2025-02-28 0000898293 us-gaap:RetainedEarningsMember 2023-09-01 2024-02-29 0000898293 us-gaap:RetainedEarningsMember 2025-02-28 0000898293 us-gaap:RetainedEarningsMember 2024-02-29 0000898293 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-11-30 0000898293 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-11-30 0000898293 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-08-31 0000898293 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-08-31 0000898293 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-01 2025-02-28 0000898293 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-01 2024-02-29 0000898293 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-01 2025-02-28 0000898293 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-02-28 0000898293 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-02-29 0000898293 us-gaap:TreasuryStockCommonMember 2024-11-30 0000898293 us-gaap:TreasuryStockCommonMember 2023-11-30 0000898293 us-gaap:TreasuryStockCommonMember 2024-08-31 0000898293 us-gaap:TreasuryStockCommonMember 2023-08-31 0000898293 us-gaap:TreasuryStockCommonMember 2024-12-01 2025-02-28 0000898293 us-gaap:TreasuryStockCommonMember 2024-09-01 2025-02-28 0000898293 us-gaap:TreasuryStockCommonMember 2023-09-01 2024-02-29 0000898293 us-gaap:TreasuryStockCommonMember 2023-12-01 2024-02-29 0000898293 us-gaap:TreasuryStockCommonMember 2025-02-28 0000898293 us-gaap:TreasuryStockCommonMember 2024-02-29 0000898293 us-gaap:NoncontrollingInterestMember 2024-11-30 0000898293 us-gaap:NoncontrollingInterestMember 2023-11-30 0000898293 us-gaap:NoncontrollingInterestMember 2024-08-31 0000898293 us-gaap:NoncontrollingInterestMember 2023-08-31 0000898293 us-gaap:NoncontrollingInterestMember 2023-12-01 2024-02-29 0000898293 us-gaap:NoncontrollingInterestMember 2023-09-01 2024-02-29 0000898293 us-gaap:NoncontrollingInterestMember 2025-02-28 0000898293 us-gaap:NoncontrollingInterestMember 2024-02-29 0000898293 2024-02-29 0000898293 jbl:TradeAccountsReceivableSaleProgramsMember 2025-02-28 0000898293 jbl:TradeAccountsReceivableSaleProgramsMember 2024-08-31 0000898293 jbl:ThreeHundredFiftyMillionDollarTradeAccountsReceivableSaleProgramMember 2025-02-28 0000898293 jbl:OneHundredMillionDollarTradeAccountsReceivableSaleProgramMember 2025-02-28 0000898293 jbl:OneThousandNineHundredMillionCNYTradeAccountsReceivableSaleProgramMember 2025-02-28 0000898293 jbl:TwoHundredThirtyMillionDollarTradeAccountsReceivableSaleProgramMember 2025-02-28 0000898293 jbl:OneHundredSeventyMillionDollarTradeAccountsReceivableSaleProgramMember 2025-02-28 0000898293 jbl:FiftyMillionDollarTradeAccountsReceivableSaleProgramMember 2025-02-28 0000898293 jbl:OneHundredMillionDollarTradeAccountsReceivableSaleProgramOneMember 2025-02-28 0000898293 jbl:OneThousandTwoHundredMillionDollarTradeAccountsReceivableSaleProgramMember 2025-02-28 0000898293 jbl:TwoHundredFiftyMillionDollarTradeAccountsReceivableSaleProgramMember 2025-02-28 0000898293 jbl:SeventyFiveMillionDollarTradeAccountsReceivableSaleProgramMember 2025-02-28 0000898293 jbl:TradeAccountsReceivableSaleProgramsMember 2024-12-01 2025-02-28 0000898293 jbl:TradeAccountsReceivableSaleProgramsMember 2023-12-01 2024-02-29 0000898293 jbl:TradeAccountsReceivableSaleProgramsMember 2024-09-01 2025-02-28 0000898293 jbl:TradeAccountsReceivableSaleProgramsMember 2023-09-01 2024-02-29 0000898293 2024-09-01 2024-09-01 0000898293 jbl:RegulatedIndustriesMember 2024-08-31 0000898293 jbl:IntelligentInfrastructureMember 2024-08-31 0000898293 jbl:ConnectedLivingAndDigitalCommerceMember 2024-08-31 0000898293 jbl:RegulatedIndustriesMember 2024-12-01 2025-02-28 0000898293 jbl:IntelligentInfrastructureMember 2024-12-01 2025-02-28 0000898293 jbl:ConnectedLivingAndDigitalCommerceMember 2024-12-01 2025-02-28 0000898293 jbl:RegulatedIndustriesMember 2025-02-28 0000898293 jbl:IntelligentInfrastructureMember 2025-02-28 0000898293 jbl:ConnectedLivingAndDigitalCommerceMember 2025-02-28 0000898293 jbl:PharmaceuticsInternationalIncMember 2024-09-01 2025-02-28 0000898293 jbl:MikrosTechnologiesLLCMember 2024-09-01 2025-02-28 0000898293 jbl:ContractualAgreementsAndCustomerRelationshipsMember 2024-09-01 2025-02-28 0000898293 jbl:ContractualAgreementsAndCustomerRelationshipsMember 2025-02-28 0000898293 jbl:ContractualAgreementsAndCustomerRelationshipsMember 2024-08-31 0000898293 us-gaap:IntellectualPropertyMember 2024-09-01 2025-02-28 0000898293 us-gaap:IntellectualPropertyMember 2025-02-28 0000898293 us-gaap:IntellectualPropertyMember 2024-08-31 0000898293 us-gaap:TradeNamesMember 2024-09-01 2025-02-28 0000898293 us-gaap:TradeNamesMember 2025-02-28 0000898293 us-gaap:TradeNamesMember 2024-08-31 0000898293 jbl:PharmaceuticsInternationalIncMember 2025-02-28 0000898293 jbl:PharmaceuticsInternationalIncMember jbl:ContractualAgreementsAndCustomerRelationshipsMember 2025-02-28 0000898293 jbl:PharmaceuticsInternationalIncMember us-gaap:IntellectualPropertyMember 2025-02-28 0000898293 jbl:MikrosTechnologiesLLCMember 2025-02-28 0000898293 jbl:MikrosTechnologiesLLCMember jbl:ContractualAgreementsAndCustomerRelationshipsMember 2025-02-28 0000898293 jbl:SeniorNotesDueJanuary2028Member us-gaap:SeniorNotesMember 2025-02-28 0000898293 jbl:SeniorNotesDueJanuary2028Member us-gaap:SeniorNotesMember 2024-08-31 0000898293 jbl:SeniorNotesDueJanuary2030Member us-gaap:SeniorNotesMember 2025-02-28 0000898293 jbl:SeniorNotesDueJanuary2030Member us-gaap:SeniorNotesMember 2024-08-31 0000898293 jbl:SeniorNotesDueJanuary2031Member us-gaap:SeniorNotesMember 2025-02-28 0000898293 jbl:SeniorNotesDueJanuary2031Member us-gaap:SeniorNotesMember 2024-08-31 0000898293 jbl:SeniorNotesDueApril2026Member us-gaap:SeniorNotesMember 2025-02-28 0000898293 jbl:SeniorNotesDueApril2026Member us-gaap:SeniorNotesMember 2024-08-31 0000898293 jbl:SeniorNotesDueMay2027Member us-gaap:SeniorNotesMember 2025-02-28 0000898293 jbl:SeniorNotesDueMay2027Member us-gaap:SeniorNotesMember 2024-08-31 0000898293 jbl:SeniorNotesDueFebruary2029Member us-gaap:SeniorNotesMember 2025-02-28 0000898293 jbl:SeniorNotesDueFebruary2029Member us-gaap:SeniorNotesMember 2024-08-31 0000898293 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2025-02-28 0000898293 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2024-08-31 0000898293 us-gaap:CommercialPaperMember us-gaap:LineOfCreditMember 2025-02-28 0000898293 jbl:AssetBackedSecuritizationsProgramMember 2025-02-28 0000898293 jbl:AssetBackedSecuritizationsProgramMember 2024-08-31 0000898293 jbl:AssetBackedSecuritizationsProgramMember 2024-12-01 2025-02-28 0000898293 jbl:AssetBackedSecuritizationsProgramMember 2023-12-01 2024-02-29 0000898293 jbl:AssetBackedSecuritizationsProgramMember 2024-09-01 2025-02-28 0000898293 jbl:AssetBackedSecuritizationsProgramMember 2023-09-01 2024-02-29 0000898293 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForwardContractsMember 2025-02-28 0000898293 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForwardContractsMember 2024-08-31 0000898293 jbl:ForeignExchangeContractDerivativeDueOctober2024Member us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForwardContractsMember 2025-02-28 0000898293 jbl:ForeignExchangeContractDerivativeDueOctober2024Member us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForwardContractsMember 2024-08-31 0000898293 jbl:ForeignExchangeContractDerivativeDueJanuary2025Member us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForwardContractsMember 2025-02-28 0000898293 jbl:ForeignExchangeContractDerivativeDueJanuary2025Member us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForwardContractsMember 2024-08-31 0000898293 jbl:ForeignExchangeContractDerivativeDueJuly2025Member us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForwardContractsMember 2025-02-28 0000898293 jbl:ForeignExchangeContractDerivativeDueJuly2025Member us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForwardContractsMember 2024-08-31 0000898293 jbl:ForeignExchangeContractDerivativeDueOctober2025Member us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForwardContractsMember 2025-02-28 0000898293 jbl:ForeignExchangeContractDerivativeDueOctober2025Member us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForwardContractsMember 2024-08-31 0000898293 jbl:ForeignExchangeContractDerivativeDueJanuary2026Member us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForwardContractsMember 2025-02-28 0000898293 jbl:ForeignExchangeContractDerivativeDueJanuary2026Member us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForwardContractsMember 2024-08-31 0000898293 jbl:ForeignExchangeContractDerivativeDueApril2026Member us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForwardContractsMember 2025-02-28 0000898293 jbl:ForeignExchangeContractDerivativeDueApril2026Member us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForwardContractsMember 2024-08-31 0000898293 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForwardContractsMember 2025-02-28 0000898293 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForwardContractsMember 2024-08-31 0000898293 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:NondesignatedMember us-gaap:ForwardContractsMember 2025-02-28 0000898293 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:NondesignatedMember us-gaap:ForwardContractsMember 2024-08-31 0000898293 us-gaap:DesignatedAsHedgingInstrumentMember 2024-12-01 2025-02-28 0000898293 us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-01 2024-02-29 0000898293 us-gaap:DesignatedAsHedgingInstrumentMember 2024-09-01 2025-02-28 0000898293 us-gaap:DesignatedAsHedgingInstrumentMember 2023-09-01 2024-02-29 0000898293 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2024-12-01 2025-02-28 0000898293 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2023-12-01 2024-02-29 0000898293 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2024-09-01 2025-02-28 0000898293 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2023-09-01 2024-02-29 0000898293 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember jbl:InterestIncomeExpenseNonoperatingMember 2024-12-01 2025-02-28 0000898293 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember jbl:InterestIncomeExpenseNonoperatingMember 2023-12-01 2024-02-29 0000898293 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember jbl:InterestIncomeExpenseNonoperatingMember 2024-09-01 2025-02-28 0000898293 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember jbl:InterestIncomeExpenseNonoperatingMember 2023-09-01 2024-02-29 0000898293 us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-12-01 2025-02-28 0000898293 us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-01 2024-02-29 0000898293 us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-09-01 2025-02-28 0000898293 us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-09-01 2024-02-29 0000898293 us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember jbl:GainLossOnDispositionOfBusinessMember 2024-12-01 2025-02-28 0000898293 us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember jbl:GainLossOnDispositionOfBusinessMember 2023-12-01 2024-02-29 0000898293 us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember jbl:GainLossOnDispositionOfBusinessMember 2024-09-01 2025-02-28 0000898293 us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember jbl:GainLossOnDispositionOfBusinessMember 2023-09-01 2024-02-29 0000898293 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2024-12-01 2025-02-28 0000898293 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2023-12-01 2024-02-29 0000898293 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2024-09-01 2025-02-28 0000898293 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2023-09-01 2024-02-29 0000898293 us-gaap:SubsequentEventMember us-gaap:ForwardContractsMember us-gaap:InterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2025-03-31 0000898293 us-gaap:AccumulatedTranslationAdjustmentMember 2024-08-31 0000898293 jbl:AccumulatedNetInvestmentHedgeAdjustmentAttributableToParentMember 2024-08-31 0000898293 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-08-31 0000898293 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2024-08-31 0000898293 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2024-08-31 0000898293 us-gaap:AccumulatedTranslationAdjustmentMember 2024-09-01 2025-02-28 0000898293 jbl:AccumulatedNetInvestmentHedgeAdjustmentAttributableToParentMember 2024-09-01 2025-02-28 0000898293 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-09-01 2025-02-28 0000898293 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2024-09-01 2025-02-28 0000898293 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2024-09-01 2025-02-28 0000898293 us-gaap:AccumulatedTranslationAdjustmentMember 2025-02-28 0000898293 jbl:AccumulatedNetInvestmentHedgeAdjustmentAttributableToParentMember 2025-02-28 0000898293 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2025-02-28 0000898293 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2025-02-28 0000898293 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2025-02-28 0000898293 us-gaap:AccumulatedTranslationAdjustmentMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2024-12-01 2025-02-28 0000898293 us-gaap:AccumulatedTranslationAdjustmentMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2023-12-01 2024-02-29 0000898293 us-gaap:AccumulatedTranslationAdjustmentMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2024-09-01 2025-02-28 0000898293 us-gaap:AccumulatedTranslationAdjustmentMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2023-09-01 2024-02-29 0000898293 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2024-12-01 2025-02-28 0000898293 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2023-12-01 2024-02-29 0000898293 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2024-09-01 2025-02-28 0000898293 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2023-09-01 2024-02-29 0000898293 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2024-12-01 2025-02-28 0000898293 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2023-12-01 2024-02-29 0000898293 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2024-09-01 2025-02-28 0000898293 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2023-09-01 2024-02-29 0000898293 us-gaap:RestrictedStockUnitsRSUMember 2024-12-01 2025-02-28 0000898293 us-gaap:RestrictedStockUnitsRSUMember 2023-12-01 2024-02-29 0000898293 us-gaap:RestrictedStockUnitsRSUMember 2024-09-01 2025-02-28 0000898293 us-gaap:RestrictedStockUnitsRSUMember 2023-09-01 2024-02-29 0000898293 us-gaap:EmployeeStockMember 2024-12-01 2025-02-28 0000898293 us-gaap:EmployeeStockMember 2023-12-01 2024-02-29 0000898293 us-gaap:EmployeeStockMember 2024-09-01 2025-02-28 0000898293 us-gaap:EmployeeStockMember 2023-09-01 2024-02-29 0000898293 jbl:A2021EquityIncentivePlanMember 2025-02-28 0000898293 jbl:TimeBasedRestrictedStockUnitsMember 2024-09-01 2025-02-28 0000898293 us-gaap:PerformanceSharesMember 2024-09-01 2025-02-28 0000898293 us-gaap:PerformanceSharesMember srt:MaximumMember 2024-09-01 2025-02-28 0000898293 jbl:MarketBasedRestrictedStockUnitsMember 2024-09-01 2025-02-28 0000898293 jbl:MarketBasedRestrictedStockUnitsMember srt:MaximumMember 2024-09-01 2025-02-28 0000898293 jbl:TimeBasedRestrictedStockUnitsMember 2023-09-01 2024-02-29 0000898293 us-gaap:PerformanceSharesMember 2023-09-01 2024-02-29 0000898293 jbl:MarketBasedRestrictedStockUnitsMember 2023-09-01 2024-02-29 0000898293 us-gaap:CommonStockMember 2024-11-30 0000898293 us-gaap:CommonStockMember 2023-11-30 0000898293 us-gaap:CommonStockMember 2024-08-31 0000898293 us-gaap:CommonStockMember 2023-08-31 0000898293 us-gaap:CommonStockMember 2024-12-01 2025-02-28 0000898293 us-gaap:CommonStockMember 2023-12-01 2024-02-29 0000898293 us-gaap:CommonStockMember 2024-09-01 2025-02-28 0000898293 us-gaap:CommonStockMember 2023-09-01 2024-02-29 0000898293 jbl:A2022ShareRepurchaseProgramMember 2021-08-31 0000898293 jbl:A2022ShareRepurchaseProgramMember 2021-06-01 2023-02-28 0000898293 jbl:A2022ShareRepurchaseProgramMember 2023-02-28 0000898293 jbl:A2023ShareRepurchaseProgramMember 2022-11-30 0000898293 jbl:A2023ShareRepurchaseProgramMember 2022-09-01 2023-08-31 0000898293 jbl:Amended2023ShareRepurchaseProgramMember 2023-11-30 0000898293 jbl:Amended2023ShareRepurchaseProgramMember 2023-09-01 2024-11-30 0000898293 jbl:Amended2023ShareRepurchaseProgramMember 2024-11-30 0000898293 jbl:A2025ShareRepurchaseProgramMember 2024-11-30 0000898293 jbl:A2025ShareRepurchaseProgramMember us-gaap:SubsequentEventMember 2024-09-01 2025-04-03 0000898293 jbl:A2025ShareRepurchaseProgramMember us-gaap:SubsequentEventMember 2025-04-03 0000898293 jbl:A2023ShareRepurchaseProgramMember 2023-09-30 0000898293 jbl:Amended2023ShareRepurchaseProgramMember 2024-09-01 2024-09-30 0000898293 jbl:A2025ShareRepurchaseProgramMember 2024-09-01 2025-02-28 0000898293 jbl:A2025ShareRepurchaseProgramMember 2025-02-28 0000898293 jbl:AcceleratedShareRepurchaseProgramMember 2023-11-30 0000898293 jbl:AcceleratedShareRepurchaseProgramMember 2023-09-01 2023-11-30 0000898293 jbl:AcceleratedShareRepurchaseProgramMember 2024-08-31 0000898293 jbl:AcceleratedShareRepurchaseProgramMember 2024-06-01 2024-08-31 0000898293 jbl:AcceleratedShareRepurchaseProgramMember 2024-09-01 2024-11-30 0000898293 jbl:AcceleratedShareRepurchaseProgramMember 2024-06-01 2024-11-30 0000898293 jbl:AcceleratedShareRepurchaseProgramMember 2025-02-28 0000898293 jbl:AcceleratedShareRepurchaseProgramMember 2024-12-01 2025-02-28 0000898293 jbl:AcceleratedShareRepurchaseProgramMember us-gaap:SubsequentEventMember 2025-03-01 2025-03-31 0000898293 jbl:AcceleratedShareRepurchaseProgramMember us-gaap:SubsequentEventMember 2024-12-01 2025-03-31 0000898293 jbl:AcceleratedShareRepurchaseProgramMember us-gaap:SubsequentEventMember 2025-03-31 0000898293 jbl:AcceleratedShareRepurchaseProgramMember 2024-12-01 2024-12-31 0000898293 jbl:A2025ShareRepurchaseProgramOpenMarketShareRepurchasesMember us-gaap:SubsequentEventMember 2024-09-01 2025-04-03 0000898293 jbl:WarrantSharesMember jbl:AmazonComNVInvestmentHoldingsLLCMember 2024-12-27 0000898293 jbl:WarrantSharesMember jbl:AmazonComNVInvestmentHoldingsLLCMember 2024-12-27 2024-12-27 0000898293 jbl:WarrantSharesMember us-gaap:MeasurementInputSharePriceMember 2024-12-27 0000898293 jbl:WarrantSharesMember us-gaap:MeasurementInputExercisePriceMember 2024-12-27 0000898293 jbl:WarrantSharesMember us-gaap:MeasurementInputExpectedTermMember 2024-12-27 0000898293 jbl:WarrantSharesMember us-gaap:MeasurementInputPriceVolatilityMember 2024-12-27 0000898293 jbl:WarrantSharesMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-12-27 0000898293 jbl:WarrantSharesMember 2024-08-31 0000898293 jbl:WarrantSharesMember 2024-09-01 2025-02-28 0000898293 jbl:WarrantSharesMember 2025-02-28 0000898293 jbl:FiveLargestCustomersMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2024-09-01 2025-02-28 0000898293 jbl:EightyEightCustomersMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2024-09-01 2025-02-28 0000898293 2023-09-01 2024-08-31 0000898293 us-gaap:TransferredAtPointInTimeMember jbl:RegulatedIndustriesMember 2024-12-01 2025-02-28 0000898293 us-gaap:TransferredOverTimeMember jbl:RegulatedIndustriesMember 2024-12-01 2025-02-28 0000898293 us-gaap:TransferredAtPointInTimeMember jbl:RegulatedIndustriesMember 2023-12-01 2024-02-29 0000898293 us-gaap:TransferredOverTimeMember jbl:RegulatedIndustriesMember 2023-12-01 2024-02-29 0000898293 jbl:RegulatedIndustriesMember 2023-12-01 2024-02-29 0000898293 us-gaap:TransferredAtPointInTimeMember jbl:IntelligentInfrastructureMember 2024-12-01 2025-02-28 0000898293 us-gaap:TransferredOverTimeMember jbl:IntelligentInfrastructureMember 2024-12-01 2025-02-28 0000898293 us-gaap:TransferredAtPointInTimeMember jbl:IntelligentInfrastructureMember 2023-12-01 2024-02-29 0000898293 us-gaap:TransferredOverTimeMember jbl:IntelligentInfrastructureMember 2023-12-01 2024-02-29 0000898293 jbl:IntelligentInfrastructureMember 2023-12-01 2024-02-29 0000898293 us-gaap:TransferredAtPointInTimeMember jbl:ConnectedLivingAndDigitalCommerceMember 2024-12-01 2025-02-28 0000898293 us-gaap:TransferredOverTimeMember jbl:ConnectedLivingAndDigitalCommerceMember 2024-12-01 2025-02-28 0000898293 us-gaap:TransferredAtPointInTimeMember jbl:ConnectedLivingAndDigitalCommerceMember 2023-12-01 2024-02-29 0000898293 us-gaap:TransferredOverTimeMember jbl:ConnectedLivingAndDigitalCommerceMember 2023-12-01 2024-02-29 0000898293 jbl:ConnectedLivingAndDigitalCommerceMember 2023-12-01 2024-02-29 0000898293 us-gaap:TransferredAtPointInTimeMember 2024-12-01 2025-02-28 0000898293 us-gaap:TransferredOverTimeMember 2024-12-01 2025-02-28 0000898293 us-gaap:TransferredAtPointInTimeMember 2023-12-01 2024-02-29 0000898293 us-gaap:TransferredOverTimeMember 2023-12-01 2024-02-29 0000898293 us-gaap:TransferredAtPointInTimeMember jbl:RegulatedIndustriesMember 2024-09-01 2025-02-28 0000898293 us-gaap:TransferredOverTimeMember jbl:RegulatedIndustriesMember 2024-09-01 2025-02-28 0000898293 jbl:RegulatedIndustriesMember 2024-09-01 2025-02-28 0000898293 us-gaap:TransferredAtPointInTimeMember jbl:RegulatedIndustriesMember 2023-09-01 2024-02-29 0000898293 us-gaap:TransferredOverTimeMember jbl:RegulatedIndustriesMember 2023-09-01 2024-02-29 0000898293 jbl:RegulatedIndustriesMember 2023-09-01 2024-02-29 0000898293 us-gaap:TransferredAtPointInTimeMember jbl:IntelligentInfrastructureMember 2024-09-01 2025-02-28 0000898293 us-gaap:TransferredOverTimeMember jbl:IntelligentInfrastructureMember 2024-09-01 2025-02-28 0000898293 jbl:IntelligentInfrastructureMember 2024-09-01 2025-02-28 0000898293 us-gaap:TransferredAtPointInTimeMember jbl:IntelligentInfrastructureMember 2023-09-01 2024-02-29 0000898293 us-gaap:TransferredOverTimeMember jbl:IntelligentInfrastructureMember 2023-09-01 2024-02-29 0000898293 jbl:IntelligentInfrastructureMember 2023-09-01 2024-02-29 0000898293 us-gaap:TransferredAtPointInTimeMember jbl:ConnectedLivingAndDigitalCommerceMember 2024-09-01 2025-02-28 0000898293 us-gaap:TransferredOverTimeMember jbl:ConnectedLivingAndDigitalCommerceMember 2024-09-01 2025-02-28 0000898293 jbl:ConnectedLivingAndDigitalCommerceMember 2024-09-01 2025-02-28 0000898293 us-gaap:TransferredAtPointInTimeMember jbl:ConnectedLivingAndDigitalCommerceMember 2023-09-01 2024-02-29 0000898293 us-gaap:TransferredOverTimeMember jbl:ConnectedLivingAndDigitalCommerceMember 2023-09-01 2024-02-29 0000898293 jbl:ConnectedLivingAndDigitalCommerceMember 2023-09-01 2024-02-29 0000898293 us-gaap:TransferredAtPointInTimeMember 2024-09-01 2025-02-28 0000898293 us-gaap:TransferredOverTimeMember 2024-09-01 2025-02-28 0000898293 us-gaap:TransferredAtPointInTimeMember 2023-09-01 2024-02-29 0000898293 us-gaap:TransferredOverTimeMember 2023-09-01 2024-02-29 0000898293 us-gaap:NonUsMember us-gaap:GeographicConcentrationRiskMember us-gaap:SalesRevenueNetMember 2024-12-01 2025-02-28 0000898293 us-gaap:NonUsMember us-gaap:GeographicConcentrationRiskMember us-gaap:SalesRevenueNetMember 2023-12-01 2024-02-29 0000898293 us-gaap:NonUsMember us-gaap:GeographicConcentrationRiskMember us-gaap:SalesRevenueNetMember 2024-09-01 2025-02-28 0000898293 us-gaap:NonUsMember us-gaap:GeographicConcentrationRiskMember us-gaap:SalesRevenueNetMember 2023-09-01 2024-02-29 0000898293 us-gaap:OperatingSegmentsMember jbl:RegulatedIndustriesMember 2024-12-01 2025-02-28 0000898293 us-gaap:OperatingSegmentsMember jbl:RegulatedIndustriesMember 2023-12-01 2024-02-29 0000898293 us-gaap:OperatingSegmentsMember jbl:RegulatedIndustriesMember 2024-09-01 2025-02-28 0000898293 us-gaap:OperatingSegmentsMember jbl:RegulatedIndustriesMember 2023-09-01 2024-02-29 0000898293 us-gaap:OperatingSegmentsMember jbl:IntelligentInfrastructureMember 2024-12-01 2025-02-28 0000898293 us-gaap:OperatingSegmentsMember jbl:IntelligentInfrastructureMember 2023-12-01 2024-02-29 0000898293 us-gaap:OperatingSegmentsMember jbl:IntelligentInfrastructureMember 2024-09-01 2025-02-28 0000898293 us-gaap:OperatingSegmentsMember jbl:IntelligentInfrastructureMember 2023-09-01 2024-02-29 0000898293 us-gaap:OperatingSegmentsMember jbl:ConnectedLivingAndDigitalCommerceMember 2024-12-01 2025-02-28 0000898293 us-gaap:OperatingSegmentsMember jbl:ConnectedLivingAndDigitalCommerceMember 2023-12-01 2024-02-29 0000898293 us-gaap:OperatingSegmentsMember jbl:ConnectedLivingAndDigitalCommerceMember 2024-09-01 2025-02-28 0000898293 us-gaap:OperatingSegmentsMember jbl:ConnectedLivingAndDigitalCommerceMember 2023-09-01 2024-02-29 0000898293 us-gaap:OperatingSegmentsMember 2024-12-01 2025-02-28 0000898293 us-gaap:OperatingSegmentsMember 2023-12-01 2024-02-29 0000898293 us-gaap:OperatingSegmentsMember 2024-09-01 2025-02-28 0000898293 us-gaap:OperatingSegmentsMember 2023-09-01 2024-02-29 0000898293 us-gaap:MaterialReconcilingItemsMember 2024-12-01 2025-02-28 0000898293 us-gaap:MaterialReconcilingItemsMember 2023-12-01 2024-02-29 0000898293 us-gaap:MaterialReconcilingItemsMember 2024-09-01 2025-02-28 0000898293 us-gaap:MaterialReconcilingItemsMember 2023-09-01 2024-02-29 0000898293 us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember jbl:MobilityBusinessMember 2023-09-01 2024-02-29 0000898293 us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember jbl:MobilityBusinessMember 2023-12-01 2024-02-29 0000898293 us-gaap:OperatingSegmentsMember jbl:RegulatedIndustriesMember 2025-02-28 0000898293 us-gaap:OperatingSegmentsMember jbl:RegulatedIndustriesMember 2024-08-31 0000898293 us-gaap:OperatingSegmentsMember jbl:IntelligentInfrastructureMember 2025-02-28 0000898293 us-gaap:OperatingSegmentsMember jbl:IntelligentInfrastructureMember 2024-08-31 0000898293 us-gaap:OperatingSegmentsMember jbl:ConnectedLivingAndDigitalCommerceMember 2025-02-28 0000898293 us-gaap:OperatingSegmentsMember jbl:ConnectedLivingAndDigitalCommerceMember 2024-08-31 0000898293 us-gaap:CorporateNonSegmentMember 2025-02-28 0000898293 us-gaap:CorporateNonSegmentMember 2024-08-31 0000898293 us-gaap:EmployeeSeveranceMember 2024-12-01 2025-02-28 0000898293 us-gaap:EmployeeSeveranceMember 2023-12-01 2024-02-29 0000898293 us-gaap:EmployeeSeveranceMember 2024-09-01 2025-02-28 0000898293 us-gaap:EmployeeSeveranceMember 2023-09-01 2024-02-29 0000898293 jbl:LeaseCostsMember 2024-12-01 2025-02-28 0000898293 jbl:LeaseCostsMember 2023-12-01 2024-02-29 0000898293 jbl:LeaseCostsMember 2024-09-01 2025-02-28 0000898293 jbl:LeaseCostsMember 2023-09-01 2024-02-29 0000898293 jbl:AssetWriteOffMember 2024-12-01 2025-02-28 0000898293 jbl:AssetWriteOffMember 2023-12-01 2024-02-29 0000898293 jbl:AssetWriteOffMember 2024-09-01 2025-02-28 0000898293 jbl:AssetWriteOffMember 2023-09-01 2024-02-29 0000898293 us-gaap:OtherRestructuringMember 2024-12-01 2025-02-28 0000898293 us-gaap:OtherRestructuringMember 2023-12-01 2024-02-29 0000898293 jbl:OtherNonAllocatedChargesMember 2024-09-01 2025-02-28 0000898293 jbl:OtherNonAllocatedChargesMember 2023-09-01 2024-02-29 0000898293 us-gaap:CorporateNonSegmentMember 2024-12-01 2025-02-28 0000898293 us-gaap:CorporateNonSegmentMember 2023-12-01 2024-02-29 0000898293 us-gaap:CorporateNonSegmentMember 2024-09-01 2025-02-28 0000898293 us-gaap:CorporateNonSegmentMember 2023-09-01 2024-02-29 0000898293 jbl:A2025RestructuringPlanMember srt:MinimumMember 2025-02-28 0000898293 jbl:A2025RestructuringPlanMember srt:MaximumMember 2025-02-28 0000898293 us-gaap:EmployeeSeveranceMember jbl:A2025RestructuringPlanMember 2024-08-31 0000898293 jbl:LeaseCostsMember jbl:A2025RestructuringPlanMember 2024-08-31 0000898293 jbl:AssetWriteOffMember jbl:A2025RestructuringPlanMember 2024-08-31 0000898293 us-gaap:OtherRestructuringMember jbl:A2025RestructuringPlanMember 2024-08-31 0000898293 jbl:A2025RestructuringPlanMember 2024-08-31 0000898293 us-gaap:EmployeeSeveranceMember jbl:A2025RestructuringPlanMember 2024-09-01 2025-02-28 0000898293 jbl:LeaseCostsMember jbl:A2025RestructuringPlanMember 2024-09-01 2025-02-28 0000898293 jbl:AssetWriteOffMember jbl:A2025RestructuringPlanMember 2024-09-01 2025-02-28 0000898293 us-gaap:OtherRestructuringMember jbl:A2025RestructuringPlanMember 2024-09-01 2025-02-28 0000898293 jbl:A2025RestructuringPlanMember 2024-09-01 2025-02-28 0000898293 us-gaap:EmployeeSeveranceMember jbl:A2025RestructuringPlanMember 2025-02-28 0000898293 jbl:LeaseCostsMember jbl:A2025RestructuringPlanMember 2025-02-28 0000898293 jbl:AssetWriteOffMember jbl:A2025RestructuringPlanMember 2025-02-28 0000898293 us-gaap:OtherRestructuringMember jbl:A2025RestructuringPlanMember 2025-02-28 0000898293 jbl:A2025RestructuringPlanMember 2025-02-28 0000898293 jbl:A2024RestructuringPlanMember 2025-02-28 0000898293 us-gaap:EmployeeSeveranceMember jbl:A2024RestructuringPlanMember 2024-08-31 0000898293 jbl:LeaseCostsMember jbl:A2024RestructuringPlanMember 2024-08-31 0000898293 jbl:AssetWriteOffMember jbl:A2024RestructuringPlanMember 2024-08-31 0000898293 us-gaap:OtherRestructuringMember jbl:A2024RestructuringPlanMember 2024-08-31 0000898293 jbl:A2024RestructuringPlanMember 2024-08-31 0000898293 us-gaap:EmployeeSeveranceMember jbl:A2024RestructuringPlanMember 2024-09-01 2025-02-28 0000898293 jbl:LeaseCostsMember jbl:A2024RestructuringPlanMember 2024-09-01 2025-02-28 0000898293 jbl:AssetWriteOffMember jbl:A2024RestructuringPlanMember 2024-09-01 2025-02-28 0000898293 us-gaap:OtherRestructuringMember jbl:A2024RestructuringPlanMember 2024-09-01 2025-02-28 0000898293 jbl:A2024RestructuringPlanMember 2024-09-01 2025-02-28 0000898293 us-gaap:EmployeeSeveranceMember jbl:A2024RestructuringPlanMember 2025-02-28 0000898293 jbl:LeaseCostsMember jbl:A2024RestructuringPlanMember 2025-02-28 0000898293 jbl:AssetWriteOffMember jbl:A2024RestructuringPlanMember 2025-02-28 0000898293 us-gaap:OtherRestructuringMember jbl:A2024RestructuringPlanMember 2025-02-28 0000898293 us-gaap:RestrictedStockUnitsRSUMember 2024-12-01 2025-02-28 0000898293 us-gaap:RestrictedStockUnitsRSUMember 2023-12-01 2024-02-29 0000898293 us-gaap:RestrictedStockUnitsRSUMember 2024-09-01 2025-02-28 0000898293 us-gaap:RestrictedStockUnitsRSUMember 2023-09-01 2024-02-29 0000898293 2024-09-01 2024-11-30 0000898293 2023-09-01 2023-11-30 0000898293 jbl:PharmaceuticsInternationalIncMember 2025-02-03 2025-02-03 0000898293 jbl:PharmaceuticsInternationalIncMember 2025-02-03 0000898293 jbl:MikrosTechnologiesLLCMember 2024-10-01 2024-10-01 0000898293 jbl:MikrosTechnologiesLLCMember 2024-10-01 0000898293 jbl:ProcureAbilityIncMember 2023-11-01 2023-11-01 0000898293 jbl:ProcureAbilityIncMember 2023-11-01 0000898293 us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember jbl:MobilityBusinessMember 2023-09-26 0000898293 us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember jbl:MobilityBusinessMember 2024-08-31 0000898293 us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember jbl:MobilityBusinessMember 2023-09-01 2024-08-31 0000898293 jbl:MobilityBusinessMember us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember us-gaap:SubsequentEventMember 2025-03-01 2025-03-31 0000898293 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2025-02-28 0000898293 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2024-08-31 0000898293 us-gaap:FairValueInputsLevel2Member us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:FairValueMeasurementsRecurringMember 2025-02-28 0000898293 us-gaap:FairValueInputsLevel2Member us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:FairValueMeasurementsRecurringMember 2024-08-31 0000898293 us-gaap:FairValueInputsLevel2Member us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:FairValueMeasurementsRecurringMember 2025-02-28 0000898293 us-gaap:FairValueInputsLevel2Member us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:FairValueMeasurementsRecurringMember 2024-08-31 0000898293 us-gaap:FairValueInputsLevel2Member us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:FairValueMeasurementsRecurringMember 2025-02-28 0000898293 us-gaap:FairValueInputsLevel2Member us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:FairValueMeasurementsRecurringMember 2024-08-31 0000898293 us-gaap:FairValueInputsLevel2Member us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:FairValueMeasurementsRecurringMember 2025-02-28 0000898293 us-gaap:FairValueInputsLevel2Member us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:FairValueMeasurementsRecurringMember 2024-08-31 0000898293 us-gaap:FairValueInputsLevel2Member jbl:SeniorNotesDueJanuary2028Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2025-02-28 0000898293 us-gaap:FairValueInputsLevel2Member jbl:SeniorNotesDueJanuary2028Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2025-02-28 0000898293 us-gaap:FairValueInputsLevel2Member jbl:SeniorNotesDueJanuary2028Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2024-08-31 0000898293 us-gaap:FairValueInputsLevel2Member jbl:SeniorNotesDueJanuary2028Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2024-08-31 0000898293 us-gaap:FairValueInputsLevel2Member jbl:SeniorNotesDueJanuary2030Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2025-02-28 0000898293 us-gaap:FairValueInputsLevel2Member jbl:SeniorNotesDueJanuary2030Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2025-02-28 0000898293 us-gaap:FairValueInputsLevel2Member jbl:SeniorNotesDueJanuary2030Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2024-08-31 0000898293 us-gaap:FairValueInputsLevel2Member jbl:SeniorNotesDueJanuary2030Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2024-08-31 0000898293 us-gaap:FairValueInputsLevel2Member jbl:SeniorNotesDueJanuary2031Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2025-02-28 0000898293 us-gaap:FairValueInputsLevel2Member jbl:SeniorNotesDueJanuary2031Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2025-02-28 0000898293 us-gaap:FairValueInputsLevel2Member jbl:SeniorNotesDueJanuary2031Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2024-08-31 0000898293 us-gaap:FairValueInputsLevel2Member jbl:SeniorNotesDueJanuary2031Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2024-08-31 0000898293 us-gaap:FairValueInputsLevel2Member jbl:SeniorNotesDueApril2026Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2025-02-28 0000898293 us-gaap:FairValueInputsLevel2Member jbl:SeniorNotesDueApril2026Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2025-02-28 0000898293 us-gaap:FairValueInputsLevel2Member jbl:SeniorNotesDueApril2026Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2024-08-31 0000898293 us-gaap:FairValueInputsLevel2Member jbl:SeniorNotesDueApril2026Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2024-08-31 0000898293 us-gaap:FairValueInputsLevel2Member jbl:SeniorNotesDueMay2027Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2025-02-28 0000898293 us-gaap:FairValueInputsLevel2Member jbl:SeniorNotesDueMay2027Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2025-02-28 0000898293 us-gaap:FairValueInputsLevel2Member jbl:SeniorNotesDueMay2027Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2024-08-31 0000898293 us-gaap:FairValueInputsLevel2Member jbl:SeniorNotesDueMay2027Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2024-08-31 0000898293 us-gaap:FairValueInputsLevel2Member jbl:SeniorNotesDueFebruary2029Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2025-02-28 0000898293 us-gaap:FairValueInputsLevel2Member jbl:SeniorNotesDueFebruary2029Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2025-02-28 0000898293 us-gaap:FairValueInputsLevel2Member jbl:SeniorNotesDueFebruary2029Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2024-08-31 0000898293 us-gaap:FairValueInputsLevel2Member jbl:SeniorNotesDueFebruary2029Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2024-08-31 0000898293 jbl:MatthewCrowleyMember 2024-12-01 2025-02-28 0000898293 jbl:MatthewCrowleyMember 2025-02-28 0000898293 jbl:MichaelDastoorMember 2024-12-01 2025-02-28 0000898293 jbl:MichaelDastoorMember 2025-02-28 0000898293 jbl:MarkT.MondelloMember 2024-12-01 2025-02-28 0000898293 jbl:MarkT.MondelloMember 2025-02-28 0000898293 jbl:GaryK.SchickMember 2024-12-01 2025-02-28 0000898293 jbl:GaryK.SchickMember 2025-02-28
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended February 28, 2025
or

☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to
Commission File Number: 001-14063

JABIL INC.
(Exact name of registrant as specified in its charter)

Delaware |  | 38-1886260
(State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification No.)

10800 Roosevelt Boulevard North, St. Petersburg, Florida 33716
(Address of principal executive offices) (Zip Code)
(727) 577-9749
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:

Title of each class | Trading symbol(s) | Name of each exchange on which registered
Common Stock, $0.001 par value per share | JBL | New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
1

Large accelerated filer | ☒ | Accelerated filer | ☐
Non-accelerated filer | ☐ | Smaller reporting company | ☐
|  | Emerging growth company | ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
As of April 3, 2025, there were 107,345,348 shares of the registrant’s Common Stock outstanding.
2

Table of Contents
JABIL INC. AND SUBSIDIARIES INDEX

Part I – Financial Information |
Item 1. | Financial Statements |
| Condensed Consolidated Balance Sheets as of February 28, 2025 and August 31, 2024 | 1
| Condensed Consolidated Statements of Operations for the three months and six months ended February 28, 2025 and February 29, 2024 | 2
| Condensed Consolidated Statements of Comprehensive Income for the three months and six months ended February 28, 2025 and February 29, 2024 | 3
| Condensed Consolidated Statements of Stockholders’ Equity for the three months and six months ended February 28, 2025 and February 29, 2024 | 4
| Condensed Consolidated Statements of Cash Flows for the six months ended February 28, 2025 and February 29, 2024 | 5
| Notes to Condensed Consolidated Financial Statements | 6
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 26
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 39
Item 4. | Controls and Procedures | 40
Part II – Other Information |
Item 1. | Legal Proceedings | 41
Item 1A. | Risk Factors | 41
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 41
Item 3. | Defaults Upon Senior Securities | 41
Item 4. | Mine Safety Disclosures | 41
Item 5. | Other Information | 42
Item 6. | Exhibits | 43
| Signatures | 45

Table of Contents
PART I—FINANCIAL INFORMATION

Item 1. | Financial Statements

JABIL INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(in millions, except for share data)

| February 28, 2025 (Unaudited) |  | August 31, 2024
ASSETS |  |  |
Current assets: |  |  |
Cash and cash equivalents | $ | 1,592 |  |  | $ | 2,201 |
Accounts receivable, net of allowance for credit losses | 3,708 |  |  | 3,533 |
Contract assets | 1,060 |  |  | 1,071 |
Inventories, net of reserve for excess and obsolete inventory | 4,435 |  |  | 4,276 |
Prepaid expenses and other current assets | 1,819 |  |  | 1,710 |
Total current assets | 12,614 |  |  | 12,791 |
Property, plant and equipment, net of accumulated depreciation of $4,848 as of February 28, 2025, and $4,736 as of August 31, 2024 | 2,880 |  |  | 3,024 |
Operating lease right-of-use assets | 401 |  |  | 360 |
Goodwill | 802 |  |  | 661 |
Intangible assets, net of accumulated amortization | 302 |  |  | 143 |
Deferred income taxes | 117 |  |  | 96 |
Other assets | 280 |  |  | 276 |
Total assets | $ | 17,396 |  |  | $ | 17,351 |
LIABILITIES AND EQUITY |  |  |
Current liabilities: |  |  |
Current installments of notes payable and long-term debt | $ | — |  |  | $ | — |
Accounts payable | 6,640 |  |  | 6,190 |
Accrued expenses | 5,584 |  |  | 5,499 |
Current operating lease liabilities | 91 |  |  | 93 |
Total current liabilities | 12,315 |  |  | 11,782 |
Notes payable and long-term debt, less current installments | 2,883 |  |  | 2,880 |
Other liabilities | 322 |  |  | 416 |
Non-current operating lease liabilities | 319 |  |  | 284 |
Income tax liabilities | 86 |  |  | 109 |
Deferred income taxes | 113 |  |  | 143 |
Total liabilities | 16,038 |  |  | 15,614 |
Commitments and contingencies |  |  |
Equity: |  |  |
Jabil Inc. stockholders’ equity: |  |  |
Preferred stock, $0.001 par value, authorized 10,000,000 shares; no shares issued and no shares outstanding | — |  |  | — |
Common stock, $0.001 par value, authorized 500,000,000 shares; 277,826,033 and 276,381,151 shares issued and 109,539,804 and 113,744,167 shares outstanding as of February 28, 2025 and August 31, 2024, respectively | — |  |  | — |
Additional paid-in capital | 3,012 |  |  | 2,841 |
Retained earnings | 5,960 |  |  | 5,760 |
Accumulated other comprehensive loss | (44) |  |  | (46) |
Treasury stock at cost, 168,286,229 and 162,636,984 shares as of February 28, 2025, and August 31, 2024, respectively | (7,570) |  |  | (6,818) |
Total Jabil Inc. stockholders’ equity | 1,358 |  |  | 1,737 |
Noncontrolling interests | — |  |  | — |
Total equity | 1,358 |  |  | 1,737 |
Total liabilities and equity | $ | 17,396 |  |  | $ | 17,351 |

See accompanying notes to Condensed Consolidated Financial Statements.
1

Table of Contents
JABIL INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in millions, except for per share data)
(Unaudited)

| Three months ended |  | Six months ended
| February 28, 2025 |  | February 29, 2024 |  | February 28, 2025 |  | February 29, 2024
Net revenue | $ | 6,728 |  |  | $ | 6,767 |  |  | $ | 13,722 |  |  | $ | 15,154 |
Cost of revenue | 6,152 |  |  | 6,137 |  |  | 12,540 |  |  | 13,749 |
Gross profit | 576 |  |  | 630 |  |  | 1,182 |  |  | 1,405 |
Operating expenses: |  |  |  |  |  |  |
Selling, general and administrative | 256 |  |  | 308 |  |  | 561 |  |  | 622 |
Research and development | 7 |  |  | 10 |  |  | 15 |  |  | 20 |
Amortization of intangibles | 15 |  |  | 9 |  |  | 28 |  |  | 15 |
Restructuring, severance and related charges | 45 |  |  | 70 |  |  | 128 |  |  | 197 |
Gain from the divestiture of businesses | — |  |  | (944) |  |  | — |  |  | (944) |
Acquisition and divestiture related charges | 8 |  |  | 46 |  |  | 8 |  |  | 61 |
Operating income | 245 |  |  | 1,131 |  |  | 442 |  |  | 1,434 |
Other expense | 24 |  |  | 22 |  |  | 44 |  |  | 43 |
Interest expense, net | 37 |  |  | 47 |  |  | 75 |  |  | 94 |
Income before income tax | 184 |  |  | 1,062 |  |  | 323 |  |  | 1,297 |
Income tax expense | 67 |  |  | 135 |  |  | 106 |  |  | 176 |
Net income | 117 |  |  | 927 |  |  | 217 |  |  | 1,121 |
Net income attributable to noncontrolling interests, net of tax | — |  |  | — |  |  | — |  |  | — |
Net income attributable to Jabil Inc. | $ | 117 |  |  | $ | 927 |  |  | $ | 217 |  |  | $ | 1,121 |
Earnings per share attributable to the stockholders of Jabil Inc.: |  |  |  |  |  |  |
Basic | $ | 1.07 |  |  | $ | 7.41 |  |  | $ | 1.95 |  |  | $ | 8.80 |
Diluted | $ | 1.06 |  |  | $ | 7.31 |  |  | $ | 1.93 |  |  | $ | 8.66 |
Weighted average shares outstanding: |  |  |  |  |  |  |
Basic | 110.0 |  |  | 125.2 |  |  | 111.3 |  |  | 127.4 |
Diluted | 111.1 |  |  | 126.9 |  |  | 112.6 |  |  | 129.5 |

See accompanying notes to Condensed Consolidated Financial Statements.
2

Table of Contents
JABIL INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(in millions)
(Unaudited)

| Three months ended |  | Six months ended
| February 28, 2025 |  | February 29, 2024 |  | February 28, 2025 |  | February 29, 2024
Net income | $ | 117 |  |  | $ | 927 |  |  | $ | 217 |  |  | $ | 1,121 |
Other comprehensive (loss) income: |  |  |  |  |  |  |
Change in foreign currency translation | (3) |  |  | (7) |  |  | (6) |  |  | (7) |
Change in derivative instruments | 11 |  |  | (3) |  |  | 7 |  |  | 10 |
Actuarial loss | (1) |  |  | (2) |  |  | (1) |  |  | (5) |
Prior service credit | 1 |  |  | 1 |  |  | 2 |  |  | 2 |
Total other comprehensive income (loss) | 8 |  |  | (11) |  |  | 2 |  |  | — |
Comprehensive income | $ | 125 |  |  | $ | 916 |  |  | $ | 219 |  |  | $ | 1,121 |
Comprehensive income attributable to noncontrolling interests | — |  |  | — |  |  | — |  |  | — |
Comprehensive income attributable to Jabil Inc. | $ | 125 |  |  | $ | 916 |  |  | $ | 219 |  |  | $ | 1,121 |

See accompanying notes to Condensed Consolidated Financial Statements.
3

Table of Contents
JABIL INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(in millions)
(Unaudited)

| Three months ended |  | Six months ended
| February 28, 2025 |  | February 29, 2024 |  | February 28, 2025 |  | February 29, 2024
Total stockholders' equity, beginning balances | $ | 1,593 |  |  | $ | 2,536 |  |  | $ | 1,737 |  |  | $ | 2,867 |
Common stock: | — |  |  | — |  |  | — |  |  | — |
Additional paid-in capital: |  |  |  |  |  |  |
Beginning balances | 3,002 |  |  | 2,827 |  |  | 2,841 |  |  | 2,795 |
Shares issued under employee stock purchase plan | 33 |  |  | 31 |  |  | 33 |  |  | 31 |
(Purchase) disposition of noncontrolling interest | — |  |  | (2) |  |  | 2 |  |  | (2) |
Treasury shares purchased | (46) |  |  | — |  |  | 69 |  |  | (13) |
Recognition of stock-based compensation | 18 |  |  | 21 |  |  | 62 |  |  | 66 |
Reclassification of liability award | 4 |  |  | — |  |  | 4 |  |  | — |
Provision for common stock warrant | 1 |  |  | — |  |  | 1 |  |  | — |
Ending balances | 3,012 |  |  | 2,877 |  |  | 3,012 |  |  | 2,877 |
Retained earnings: |  |  |  |  |  |  |
Beginning balances | 5,851 |  |  | 4,595 |  |  | 5,760 |  |  | 4,412 |
Declared dividends | (8) |  |  | (10) |  |  | (17) |  |  | (21) |
Net income attributable to Jabil Inc. | 117 |  |  | 927 |  |  | 217 |  |  | 1,121 |
Ending balances | 5,960 |  |  | 5,512 |  |  | 5,960 |  |  | 5,512 |
Accumulated other comprehensive loss: |  |  |  |  |  |  |
Beginning balances | (52) |  |  | (6) |  |  | (46) |  |  | (17) |
Total other comprehensive income (loss) | 8 |  |  | (11) |  |  | 2 |  |  | — |
Ending balances | (44) |  |  | (17) |  |  | (44) |  |  | (17) |
Treasury stock: |  |  |  |  |  |  |
Beginning balances | (7,208) |  |  | (4,881) |  |  | (6,818) |  |  | (4,324) |
Purchases of treasury stock under employee stock plans | (1) |  |  | — |  |  | (41) |  |  | (67) |
Treasury shares purchased | (358) |  |  | (825) |  |  | (705) |  |  | (1,312) |
Excise taxes related to treasury shares purchased | (3) |  |  | (8) |  |  | (6) |  |  | (11) |
Ending balances | (7,570) |  |  | (5,714) |  |  | (7,570) |  |  | (5,714) |
Noncontrolling interests: |  |  |  |  |  |  |
Beginning balances | — |  |  | 1 |  |  | — |  |  | 1 |
Net income attributable to noncontrolling interests | — |  |  | — |  |  | — |  |  | — |
Purchase of noncontrolling interest | — |  |  | (1) |  |  | — |  |  | (1) |
Ending balances | — |  |  | — |  |  | — |  |  | — |
Total stockholders' equity, ending balances | $ | 1,358 |  |  | $ | 2,658 |  |  | $ | 1,358 |  |  | $ | 2,658 |

See accompanying notes to Condensed Consolidated Financial Statements.
4

Table of Contents
JABIL INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in millions)
(Unaudited)

| Six months ended
| February 28, 2025 |  | February 29, 2024
Cash flows provided by operating activities: |  |  |
Net income | $ | 217 |  |  | $ | 1,121 |
Depreciation, amortization, and other, net | 373 |  |  | 356 |
Gain from the divestiture of businesses | — |  |  | (944) |
Change in operating assets and liabilities, exclusive of net assets acquired | 56 |  |  | 133 |
Net cash provided by operating activities | 646 |  |  | 666 |
Cash flows (used in) provided by investing activities: |  |  |
Acquisition of property, plant and equipment | (213) |  |  | (554) |
Proceeds and advances from sale of property, plant and equipment | 54 |  |  | 109 |
Cash paid for business and intangible asset acquisitions, net of cash | (361) |  |  | (93) |
Proceeds from the divestiture of businesses, net of cash | — |  |  | 2,108 |
Other, net | 17 |  |  | (12) |
Net cash (used in) provided by investing activities | (503) |  |  | 1,558 |
Cash flows used in financing activities: |  |  |
Borrowings under debt agreements | 334 |  |  | 1,799 |
Payments toward debt agreements | (414) |  |  | (1,866) |
Payments to acquire treasury stock | (636) |  |  | (1,325) |
Dividends paid to stockholders | (19) |  |  | (22) |
Net proceeds from exercise of stock options and issuance of common stock under employee stock purchase plan | 33 |  |  | 31 |
Treasury stock minimum tax withholding related to vesting of restricted stock | (41) |  |  | (67) |
Other, net | (3) |  |  | (5) |
Net cash used in financing activities | (746) |  |  | (1,455) |
Effect of exchange rate changes on cash and cash equivalents | (6) |  |  | (7) |
Net (decrease) increase in cash and cash equivalents | (609) |  |  | 762 |
Cash and cash equivalents at beginning of period | 2,201 |  |  | 1,804 |
Cash and cash equivalents at end of period | $ | 1,592 |  |  | $ | 2,566 |

See accompanying notes to Condensed Consolidated Financial Statements.
5

Table of Contents
JABIL INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
1. Basis of Presentation
The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) necessary to present fairly the information set forth therein have been included. The accompanying unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and footnotes included in the Annual Report on Form 10-K of Jabil Inc. (the “Company”) for the fiscal year ended August 31, 2024. Results for the six months ended February 28, 2025, are not necessarily an indication of the results that may be expected for the full fiscal year ending August 31, 2025. The Company has made certain reclassification adjustments to conform prior period amounts to the current presentation, including adjustments related to the change in reportable segments. See Note 13 – “Concentration of Risk and Segment Data” to the Condensed Consolidated Financial Statements for additional information.
2. Trade Accounts Receivable Sale Programs
The Company regularly sells designated pools of high credit quality trade accounts receivable under uncommitted trade accounts receivable sale programs to unaffiliated financial institutions without recourse. As these accounts receivable are sold without recourse, the Company does not retain the associated risks following the transfer of such accounts receivable to the respective financial institutions. The Company continues servicing the receivables sold and in exchange receives an immaterial servicing fee under each of the trade accounts receivable sale programs. The Company does not record a servicing asset or liability on the Condensed Consolidated Balance Sheets as the Company estimates that the fee it receives to service these receivables approximates the fair market compensation to provide the servicing activities.
In conjunction with the trade accounts receivable sale programs, the Company is required to remit amounts collected as a servicer under the trade accounts receivable sale programs to the unaffiliated financial institutions that purchased the receivables. The outstanding balance of receivables sold and not yet collected on accounts where the Company has continuing involvement was approximately $571 million and $367 million as of February 28, 2025, and August 31, 2024, respectively. Transfers of the receivables under the trade accounts receivable sale programs are accounted for as sales and, accordingly, net receivables sold under the trade accounts receivable sale programs are excluded from accounts receivable on the Condensed Consolidated Balance Sheets and are reflected as cash provided by operating activities on the Condensed Consolidated Statements of Cash Flows.
The following is a summary of the Company’s uncommitted trade accounts receivable sale programs with unaffiliated financial institutions where the Company may elect to sell receivables and the unaffiliated financial institution may elect to purchase, at a discount, on an ongoing basis (in millions):

Program |  | Maximum Amount(1)(2) |  |  |  |
A |  | $ | 350 |  |  |  |  |  |
B |  | $ | 100 |  |  |  |  |  |
C |  | 1,900 |  | CNY |  |  |  |
D |  | $ | 230 |  |  |  |  |  |
E |  | $ | 170 |  |  |  |  |  |
F |  | $ | 50 |  |  |  |  |  |
G |  | $ | 100 |  |  |  |  |  |
H |  | $ | 1,200 |  |  |  |  |  |
I |  | $ | 250 |  |  |  |  |  |
J |  | $ | 75 |  |  |  |  |  |

(1)Maximum amount of trade accounts receivable that may be sold under a facility at any one time.
(2)The trade accounts receivable sale programs either expire on various dates through 2028 or do not have expiration dates and may be terminated upon election of the Company or the unaffiliated financial institutions.
6

Table of Contents
In connection with the trade accounts receivable sale programs, the Company recognized the following (in millions):

| Three months ended |  | Six months ended
| February 28, 2025 |  | February 29, 2024 |  | February 28, 2025 |  | February 29, 2024
Trade accounts receivable sold | $ | 2,027 |  |  | $ | 1,818 |  |  | $ | 3,713 |  |  | $ | 3,854 |
Cash proceeds received | $ | 2,016 |  |  | $ | 1,809 |  |  | $ | 3,692 |  |  | $ | 3,834 |
Pre-tax losses on sale of receivables(1) | $ | 11 |  |  | $ | 9 |  |  | $ | 21 |  |  | $ | 20 |

(1)Recorded to other expense within the Condensed Consolidated Statements of Operations.
3. Inventories
Inventories consist of the following (in millions):

| February 28, 2025 |  | August 31, 2024
Raw materials | $ | 3,856 |  |  | $ | 3,903 |
Work in process | 312 |  |  | 190 |
Finished goods | 340 |  |  | 246 |
Reserve for excess and obsolete inventory | (73) |  |  | (63) |
Inventories, net | $ | 4,435 |  |  | $ | 4,276 |

The Company is responsible for procuring certain components from suppliers for the manufacturing of finished goods at the direction of certain customers. If the Company does not obtain control of these components before they are transferred to the customer, the Company accounts for revenue and cost of revenue associated with such components on a net basis. Revenue and cost of revenue associated with components procured directly from customers is accounted for on a net basis if the components do not constitute a distinct good or service from the customer. As of February 28, 2025, and August 31, 2024, the Company had $951 million and $734 million, respectively, of components included in prepaid expenses and other current assets in the Company’s Condensed Consolidated Balance Sheets, related to purchases made to procure components for customers whereby the associated revenue is expected to be accounted for on a net basis once transferred to the customer.
4. Leases
During fiscal year 2025, the Company entered into new operating and finance leases. The future minimum lease payments under these new leases as of February 28, 2025, were as follows (in millions):

| Payments due by period
| Total |  | Less than 1 year |  | 1-3 years |  | 3-5 years |  | After 5 years
Operating lease obligations(1) | $ | 105 |  |  | $ | 14 |  |  | $ | 25 |  |  | $ | 21 |  |  | $ | 45 |
Finance lease obligations | $ | 57 |  |  | $ | 48 |  |  | $ | 8 |  |  | $ | 1 |  |  | $ | — |

(1)Excludes $91 million of payments related to leases signed but not yet commenced.
5. Goodwill and Other Intangible Assets
Beginning September 1, 2024, the Company reorganized its internal structure to focus on speed, precision, and solutions, and as a result of the organizational realignment, the Company’s operating segments now consist of three segments – Regulated Industries, Intelligent Infrastructure, and Connected Living and Digital Commerce, which are also the Company’s reportable segments. See Note 13 – “Concentration of Risk and Segment Data” to the Condensed Consolidated Financial Statements for additional information.
The Company performs a goodwill impairment analysis on an annual basis and whenever events or changes in circumstances indicate that the carrying value may not be recoverable. As a result of the change in reportable segments, the Company’s reporting units also changed. In connection with the preparation of the Company’s financial statements for the quarter ended November 30, 2024, the Company tested goodwill for impairment immediately before and after the reorganization. As a result of these analyses, the Company determined that goodwill was not impaired before or after the reorganization.
7

Table of Contents
The following table presents the changes in goodwill allocated to the Company’s reportable segments during the six months ended February 28, 2025 (in millions):

| Regulated Industries |  | Intelligent Infrastructure |  | Connected Living and Digital Commerce |  | Total
Balance as of September 1, 2024 | $ | 490 |  |  | $ | 69 |  |  | $ | 102 |  |  | $ | 661 |
Acquisitions and adjustments(1) | 132 |  |  | 17 |  |  | — |  |  | 149 |
Change in foreign currency exchange rates | (7) |  |  | — |  |  | (1) |  |  | (8) |
Balance as of February 28, 2025 | $ | 615 |  |  | $ | 86 |  |  | $ | 101 |  |  | $ | 802 |

(1)During the fiscal year 2025 and in connection with the acquisitions of Pharmaceutics International, Inc. (“Pii”) and Mikros Technologies LLC (“Mikros Technologies”), the Company recognized goodwill of $132 million and $17 million, respectively. See Note 17 – “Business Acquisitions and Divestitures” for additional information.
The following table is a summary of the Company’s gross goodwill balances and accumulated impairments as of the periods indicated (in millions):

| February 28, 2025 |  | August 31, 2024
| Gross Carrying Amount |  | Accumulated Impairment |  | Gross Carrying Amount |  | Accumulated Impairment
Goodwill | $ | 1,822 |  |  | $ | 1,020 |  |  | $ | 1,681 |  |  | $ | 1,020 |

The following table presents the Company’s total purchased intangible assets as of the periods indicated (in millions):

| Weighted Average Amortization Period (in years) |  | February 28, 2025(1) |  | August 31, 2024
|  | Gross Carrying Amount |  | Accumulated Amortization |  | Net Carrying Amount |  | Gross Carrying Amount |  | Accumulated Amortization |  | Net Carrying Amount
Contractual agreements and customer relationships | 11 |  | $ | 495 |  |  | $ | (278) |  |  | $ | 217 |  |  | $ | 361 |  |  | $ | (270) |  |  | $ | 91 |
Intellectual property | 9 |  | 243 |  |  | (184) |  |  | 59 |  |  | 198 |  |  | (181) |  |  | 17 |
Finite-lived trade names | 2 |  | 134 |  |  | (108) |  |  | 26 |  |  | 130 |  |  | (95) |  |  | 35 |
Total intangible assets | 10 |  | $ | 872 |  |  | $ | (570) |  |  | $ | 302 |  |  | $ | 689 |  |  | $ | (546) |  |  | $ | 143 |

(1)In connection with the acquisition of Pii, the Company acquired $149 million of intangible assets, including $109 million assigned to contractual agreements and customer relationships and $38 million assigned to intellectual property. In connection with the acquisition of Mikros Technologies, the Company acquired $40 million of intangible assets, including $31 million assigned to contractual agreements and customer relationships. See Note 17 – “Business Acquisitions and Divestitures” for additional information.
Intangible asset amortization during the three months and six months ended February 28, 2025 was approximately $15 million and $28 million, respectively. Intangible asset amortization during the three months and six months ended February 29, 2024 was approximately $9 million and $15 million, respectively. The estimated future amortization expense is as follows (in millions):

Fiscal Year Ended August 31, |
2025 | $ | 34 |
2026 | 49 |
2027 | 39 |
2028 | 36 |
2029 | 29 |
Thereafter | 115 |
Total | $ | 302 |

8

Table of Contents
6. Notes Payable and Long-Term Debt
Notes payable and long-term debt outstanding as of February 28, 2025, and August 31, 2024, are summarized below (in millions):

|  | Maturity Date |  | February 28, 2025 |  | August 31, 2024
3.950% Senior Notes |  | Jan 12, 2028 |  | $ | 498 |  |  | $ | 498 |
3.600% Senior Notes |  | Jan 15, 2030 |  | 497 |  |  | 497 |
3.000% Senior Notes |  | Jan 15, 2031 |  | 595 |  |  | 594 |
1.700% Senior Notes |  | Apr 15, 2026 |  | 499 |  |  | 499 |
4.250% Senior Notes |  | May 15, 2027 |  | 497 |  |  | 496 |
5.450% Senior Notes |  | Feb 1, 2029 |  | 297 |  |  | 296 |
Borrowings under credit facilities(1) |  | Jan 22, 2026 and Jan 22, 2028 |  | — |  |  | — |
Total notes payable and long-term debt |  |  |  | 2,883 |  |  | 2,880 |
Less current installments of notes payable and long-term debt |  |  |  | — |  |  | — |
Notes payable and long-term debt, less current installments |  |  |  | $ | 2,883 |  |  | $ | 2,880 |

(1)As of February 28, 2025, the Company has $4.0 billion in available unused borrowing capacity under its revolving credit facilities. The Credit Facility acts as the back-up facility for commercial paper outstanding, if any. The Company has a borrowing capacity of up to $3.2 billion under its commercial paper program.
Debt Covenants
Borrowings under the Company’s debt agreements are subject to various covenants that limit the Company’s ability to: incur additional indebtedness, sell assets, effect mergers and certain transactions, and effect certain transactions with subsidiaries and affiliates. In addition, the revolving credit facilities contain debt leverage and interest coverage covenants. The Company is also subject to certain covenants requiring the Company to offer to repurchase the 3.950%, 3.600%, 3.000%, 1.700%, 4.250% or 5.450% Senior Notes upon a change of control. As of February 28, 2025, and August 31, 2024, the Company was in compliance with its debt covenants.
Fair Value
Refer to Note 18 – “Fair Value Measurements” for the estimated fair values of the Company’s notes payable and long-term debt.
7. Asset-Backed Securitization Program
Certain Jabil entities participating in the global asset-backed securitization program continuously sell designated pools of trade accounts receivable to a special purpose entity, which in turn sells certain of the receivables at a discount to conduits administered by an unaffiliated financial institution on a monthly basis. In addition, a foreign entity participating in the global asset-backed securitization program sells certain receivables at a discount to conduits administered by an unaffiliated financial institution on a daily basis. As these accounts receivable are sold without recourse, the Company does not retain the associated risks following the transfer of such accounts receivable to the respective financial institutions.
The Company continues servicing the receivables sold and in exchange receives an immaterial servicing fee under the global asset-backed securitization program. The Company does not record a servicing asset or liability on the Condensed Consolidated Balance Sheets as the Company estimates that the fee it receives to service these receivables approximates the fair market compensation to provide the servicing activities.
The special purpose entity in the global asset-backed securitization program is a wholly owned subsidiary of the Company and is included in the Company’s Condensed Consolidated Financial Statements. Certain unsold receivables covering up to the maximum amount of net cash proceeds available under the domestic, or U.S., portion of the global asset-backed securitization program are pledged as collateral to the unaffiliated financial institution as of February 28, 2025.
Effective January 23, 2025, the terms of the global asset-backed securitization program were amended to extend the termination date from January 2025 to January 2028. The maximum amount of net cash proceeds available at any one time is $700 million.
9

Table of Contents
In conjunction with the global asset-backed securitization program, the Company is required to remit amounts collected as a servicer under the global asset-backed securitization program to a special purpose entity, which in turn sells certain receivables to unaffiliated financial institutions that purchased the receivables. The outstanding balance of receivables sold and not yet collected on accounts where the Company has continuing involvement was approximately $368 million and $338 million as of February 28, 2025, and August 31, 2024, respectively. Transfers of the receivables under the asset-backed securitization program are accounted for as sales and, accordingly, net receivables sold under the asset-backed securitization program are excluded from accounts receivable on the Condensed Consolidated Balance Sheets and are reflected as cash provided by operating activities on the Condensed Consolidated Statements of Cash Flows.
In connection with the asset-backed securitization program, the Company recognized the following (in millions):

| Three months ended |  | Six months ended
| February 28, 2025 |  | February 29, 2024 |  | February 28, 2025 |  | February 29, 2024
Trade accounts receivable sold | $ | 980 |  |  | $ | 968 |  |  | $ | 2,047 |  |  | $ | 1,957 |
Cash proceeds received(1) | $ | 970 |  |  | $ | 955 |  |  | $ | 2,025 |  |  | $ | 1,934 |
Pre-tax losses on sale of receivables(2) | $ | 10 |  |  | $ | 13 |  |  | $ | 22 |  |  | $ | 23 |

(1)The amounts primarily represent proceeds from collections reinvested in revolving-period transfers.
(2)Recorded to other expense within the Condensed Consolidated Statements of Operations.
The global asset-backed securitization program requires compliance with several covenants including compliance with the interest ratio and debt to EBITDA ratio of the Credit Facility. As of February 28, 2025, and August 31, 2024, the Company was in compliance with all covenants under the global asset-backed securitization program.
8. Accrued Expenses
Accrued expenses consist of the following (in millions):

| February 28, 2025 |  | August 31, 2024
Inventory deposits | $ | 1,340 |  |  | $ | 1,582 |
Contract liabilities(1) | 1,076 |  |  | 1,017 |
Accrued compensation and employee benefits | 552 |  |  | 699 |
Other accrued expenses | 2,616 |  |  | 2,201 |
Accrued expenses | $ | 5,584 |  |  | $ | 5,499 |

(1)Revenue recognized during the three months and six months ended February 28, 2025 that was included in the contract liability balance as of August 31, 2024, was $139 million and $289 million, respectively. Revenue recognized during the three months and six months ended February 29, 2024, that was included in the contract liability balance as of August 31, 2023, was $114 million and $275 million, respectively.
9. Postretirement and Other Employee Benefits
Net Periodic Benefit Cost
The following table provides information about the net periodic benefit cost for all plans for the three months and six months ended February 28, 2025, and February 29, 2024 (in millions):

| Three months ended |  | Six months ended
| February 28, 2025 |  | February 29, 2024 |  | February 28, 2025 |  | February 29, 2024
Service cost(1) | $ | 5 |  |  | $ | 5 |  |  | $ | 11 |  |  | $ | 10 |
Interest cost(2) | 2 |  |  | 3 |  |  | 5 |  |  | 6 |
Expected long-term return on plan assets(2) | (4) |  |  | (5) |  |  | (9) |  |  | (9) |
Recognized actuarial gain(2) | — |  |  | (1) |  |  | — |  |  | (3) |
Amortization of actuarial gain(2)(3) | (1) |  |  | (1) |  |  | (1) |  |  | (2) |
Amortization of prior service cost(2) | 2 |  |  | 1 |  |  | 3 |  |  | 2 |
Net periodic benefit cost | $ | 4 |  |  | $ | 2 |  |  | $ | 9 |  |  | $ | 4 |

(1)Service cost is recognized in cost of revenue in the Condensed Consolidated Statements of Operations.
10

Table of Contents
(2)Components are recognized in other expense in the Condensed Consolidated Statements of Operations.
(3)Actuarial gains and losses are amortized using a corridor approach. The gain/loss corridor is equal to 10 percent of the greater of the projected benefit obligation and the fair value of plan assets. Gains and losses in excess of the corridor are generally amortized over the average future working lifetime of the plan participants.
10. Derivative Financial Instruments and Hedging Activities
The Company is directly and indirectly affected by changes in certain market conditions. These changes in market conditions may adversely impact the Company’s financial performance and are referred to as market risks. The Company, where deemed appropriate, uses derivatives as risk management tools to mitigate the potential impact of certain market risks. The primary market risks managed by the Company through the use of derivative instruments are foreign currency risk and interest rate risk.
All derivative instruments are recorded gross on the Condensed Consolidated Balance Sheets at their respective fair values. Changes in fair value of derivative instruments are recorded in the Condensed Consolidated Statements of Operations, or as a component of AOCI in the Condensed Consolidated Balance Sheets, as discussed below.
Foreign Currency Risk Management
The Company enters into forward foreign exchange contracts to manage the foreign currency risk associated with the anticipated foreign currency denominated revenues and expenses.
Cash Flow Hedges
The Company enters into forward foreign exchange contracts to effectively lock in the value of anticipated foreign currency denominated revenues and expenses against foreign currency fluctuations. The related forward foreign exchange contracts have been designated as hedging instruments and are accounted for as cash flow hedges. The effective portion of the gain or loss on cash flow hedges is initially reported as a component of AOCI, net of tax, and is subsequently reclassified into the line item within the Condensed Consolidated Statements of Operations in which the hedged items are recorded, in the same period in which the hedged item affects earnings. The gains and losses recognized in earnings due to hedge ineffectiveness and the amount excluded from effectiveness testing are included as components of net revenue, cost of revenue and selling, general and administrative expense, which are the same line items in which the hedged items are recorded. The aggregate notional amount of these outstanding contracts as of February 28, 2025, and August 31, 2024, was $315 million and $353 million, respectively. The anticipated foreign currency denominated revenues and expenses being hedged are expected to occur between March 1, 2025, and November 30, 2025.
Net Investment Hedges
In addition, the Company has entered into forward foreign exchange contracts to hedge a portion of its net investment in foreign currency denominated operations, which are designated as net investment hedges. The effective portion of the gain or loss is included in change in foreign currency translation in OCI to offset the change in the carrying value of the net investment being hedged until the complete or substantially complete liquidation of the hedged foreign operation. The gains and losses recognized in earnings due to hedge ineffectiveness and the amounts excluded from effectiveness testing are included in interest expense, net. The maturity dates and aggregate notional amount of these outstanding contracts are as follows (in millions):

Maturity date | February 28, 2025 |  | August 31, 2024
October 2024 | $ | — |  |  | $ | 140 |
January 2025 | — |  |  | 106 |
July 2025 | 126 |  |  | 55 |
October 2025 | 93 |  |  | — |
January 2026 | 100 |  |  | 106 |
April 2026 | 41 |  |  | — |
Total | $ | 360 |  |  | $ | 407 |

11

Table of Contents
Non-Designated Derivatives
In addition to derivatives that are designated as hedging instruments and qualify for hedge accounting, the Company also enters into forward foreign exchange contracts to economically hedge transactional exposure associated with commitments arising from trade accounts receivable, trade accounts payable, fixed purchase obligations and intercompany transactions denominated in a currency other than the functional currency of the respective operating entity. The gains and losses from changes in fair values are recognized immediately in current earnings. The aggregate notional amount of these outstanding contracts as of February 28, 2025, and August 31, 2024, was $2.7 billion and $2.6 billion, respectively.
The Effect of Derivative Instruments on AOCI and the Condensed Consolidated Statements of Operations
The following table sets forth the gains and losses of the Company's derivative instruments designated as cash flow hedges and net investment hedges in OCI, and not designated as hedging instruments in the Condensed Consolidated Statements of Operations for the periods presented (in millions):

|  |  |  | Three months ended |  | Six months ended
|  | Financial Statement Line Item |  | February 28, 2025 |  | February 29, 2024 |  | February 28, 2025 |  | February 29, 2024
Derivative instruments designated as cash flow hedges: |  |  |  |  |  |  |  |  |  |
Gains (losses) recognized in OCI(1) |  |  |  | $ | 1 |  |  | $ | (1) |  |  | $ | (11) |  |  | $ | (4) |
Losses (gains) reclassified from AOCI into earnings(1)(2) |  |  |  |  |  |  |  |  |  |
Forward foreign exchange contracts |  | Cost of revenue |  | $ | 11 |  |  | $ | (2) |  |  | $ | 20 |  |  | $ | 15 |
Interest rate contracts |  | Interest expense, net |  | $ | (1) |  |  | $ | — |  |  | $ | (2) |  |  | $ | (1) |
Derivative instruments designated as net investment hedges: |  |  |  |  |  |  |  |  |  |
Gains recognized in OCI(1) |  |  |  | $ | 7 |  |  | $ | 4 |  |  | $ | 28 |  |  | $ | — |
(Gains) reclassified from AOCI into earnings(1) |  | Gain from the divestiture of businesses |  | $ | — |  |  | $ | (4) |  |  | $ | — |  |  | $ | (4) |
Derivative instruments not designated as hedging instruments: |  |  |  |  |  |  |  |  |  |
(Losses) gains recognized in earnings from forward foreign exchange contracts |  | Cost of revenue |  | $ | (5) |  |  | $ | (11) |  |  | $ | (26) |  |  | $ | 7 |
(Losses) gains recognized in earnings from changes in foreign currency |  | Cost of revenue |  | $ | (7) |  |  | $ | 3 |  |  | $ | 3 |  |  | $ | (35) |

(1)Amounts are net of tax, which are immaterial for the three months and six months ended February 28, 2025, and February 29, 2024.
(2)The Company expects to reclassify $1 million into earnings during the next twelve months, which will primarily be classified as a component of cost of revenue.
The gains and losses recognized in earnings due to amounts excluded from effectiveness testing were not material for all periods presented.
Refer to Note 18 – “Fair Value Measurements” for the fair values and classification of the Company’s derivative instruments.
Interest Rate Risk Management
The Company periodically enters into interest rate swaps to manage interest rate risk associated with the Company’s borrowings or anticipated debt issuances. As of February 28, 2025, there are no outstanding interest rate swaps.
12

Table of Contents
In March 2025, the Company entered into forward interest rate swap transactions to hedge the fixed interest rate payments for an anticipated debt issuance or the contractually specified SOFR interest rates for anticipated term loan borrowings. The forward interest rate swaps have an aggregate notional amount of $100 million and have been designated as hedging instruments and accounted for as cash flow hedges. The forward interest rate swaps are scheduled to expire on July 31, 2026. If the anticipated debt issuance or term loan borrowings occurs before July 31, 2026, the contracts will be terminated simultaneously with the debt issuance or term loan borrowings. The contracts will be settled with the respective counterparties on a net basis at the time of termination or expiration. Changes in the fair value of the forward interest rate swap transactions will be recorded on the Condensed Consolidated Balance Sheets as a component of AOCI.
11. Accumulated Other Comprehensive Income
The following table sets forth the changes in AOCI, net of tax, by component for the six months ended February 28, 2025 (in millions):

| Foreign Currency Translation Adjustment |  | Net Investment Hedges |  | Derivative Instruments |  | Actuarial Gain (Loss) |  | Prior Service (Cost) Credit |  | Total
Balance as of August 31, 2024 | $ | (44) |  |  | $ | (24) |  |  | $ | 12 |  |  | $ | 29 |  |  | $ | (19) |  |  | $ | (46) |
Other comprehensive (loss) income before reclassifications | (34) |  |  | 28 |  |  | (11) |  |  | — |  |  | — |  |  | (17) |
Amounts reclassified from AOCI | — |  |  | — |  |  | 18 |  |  | (1) |  |  | 2 |  |  | 19 |
Other comprehensive (loss) income(1) | (34) |  |  | 28 |  |  | 7 |  |  | (1) |  |  | 2 |  |  | 2 |
Balance as of February 28, 2025 | $ | (78) |  |  | $ | 4 |  |  | $ | 19 |  |  | $ | 28 |  |  | $ | (17) |  |  | $ | (44) |

(1)Amounts are net of tax, which are immaterial.
The following table sets forth the amounts reclassified from AOCI into the Condensed Consolidated Statements of Operations, and the associated financial statement line item, net of tax, for the periods indicated (in millions):

|  |  |  | Three months ended(1) |  | Six months ended(1)
Comprehensive Income Components |  | Financial Statement Line Item |  | February 28, 2025 |  | February 29, 2024 |  | February 28, 2025 |  | February 29, 2024
Realized gains on foreign currency translation |  | Gain from the divestiture of businesses |  | $ | — |  |  | $ | (2) |  |  | $ | — |  |  | $ | (2) |
Realized (gains) losses on pension and postretirement plans: |  |  |  |  |  |  |  |  |  |
Actuarial gains |  | (2) |  | $ | (1) |  |  | $ | (2) |  |  | $ | (1) |  |  | $ | (5) |
Prior service costs |  | (2) |  | $ | 1 |  |  | $ | 1 |  |  | $ | 2 |  |  | $ | 2 |

(1)Amounts are net of tax, which are immaterial for the three months and six months ended February 28, 2025 and February 29, 2024.
(2)Amounts are included in the computation of net periodic benefit cost. Refer to Note 9 – “Postretirement and Other Employee Benefits” for additional information.
12. Stockholders’ Equity
The Company recognized stock-based compensation expense within selling, general and administrative expense as follows (in millions):

| Three months ended |  | Six months ended
| February 28, 2025 |  | February 29, 2024 |  | February 28, 2025 |  | February 29, 2024
Restricted stock units | $ | 15 |  |  | $ | 18 |  |  | $ | 55 |  |  | $ | 60 |
Employee stock purchase plan | 6 |  |  | 5 |  |  | 10 |  |  | 9 |
Total | $ | 21 |  |  | $ | 23 |  |  | $ | 65 |  |  | $ | 69 |

As of February 28, 2025, the shares available to be issued under t he 2021 Equity Incentive Plan were 7,117,366.
13

Table of Contents
Restricted Stock Units
Certain key employees have been granted time-based, performance-based and market-based restricted stock unit awards (“restricted stock units”). The time-based restricted stock units generally vest on a graded vesting schedule over three years. The performance-based restricted stock units generally vest on a cliff vesting schedule over three years and up to a maximum of 200%, depending on the specified performance condition and the level of achievement obtained. The performance-based restricted stock units have a vesting condition that is based upon the Company’s cumulative adjusted core earnings per share during the performance period. The market-based restricted stock units generally vest on a cliff vesting schedule over three years and up to a maximum of 200%, depending on the specified performance condition and the level of achievement obtained. The market-based restricted stock units have a vesting condition that is tied to the Company’s total shareholder return based on the Company’s stock performance in relation to the companies in the Standard and Poor’s (S&P) Super Composite Technology Hardware and Equipment Index excluding the Company. During the six months ended February 28, 2025, and 2024, the Company awarded approximately 0.6 million and 0.4 million time-based restricted stock units, respectively, 0.1 million and 0.1 million performance-based restricted stock units, respectively, and 0.1 million and 0.1 million market-based restricted stock units, respectively.
The following represents the stock-based compensation information as of the period indicated (in millions):

| February 28, 2025
Unrecognized stock-based compensation expense – restricted stock units | $ | 86 |
Remaining weighted-average period for restricted stock units expense | 1.6 years

Common Stock Outstanding
The following represents the common stock outstanding for the periods indicated:

| Three months ended |  | Six months ended
| February 28, 2025 |  | February 29, 2024 |  | February 28, 2025 |  | February 29, 2024
Common stock outstanding: |  |  |  |  |  |  |
Beginning balances | 111,693,059 |  |  | 128,647,431 |  |  | 113,744,167 |  |  | 131,294,422 |
Shares issued under employee stock purchase plan | 355,851 |  |  | 338,316 |  |  | 355,851 |  |  | 338,316 |
Vesting of restricted stock | 6,419 |  |  | 2,741 |  |  | 1,089,031 |  |  | 1,769,516 |
Purchases of treasury stock under employee stock plans | (991) |  |  | (795) |  |  | (323,991) |  |  | (526,823) |
Treasury shares purchased | (2,514,534) |  |  | (6,547,086) |  |  | (5,325,254) |  |  | (10,434,824) |
Ending balances | 109,539,804 |  |  | 122,440,607 |  |  | 109,539,804 |  |  | 122,440,607 |

Treasury Shares Purchased
The Company repurchases shares of its common stock under share repurchase programs authorized by the Company’s Board of Directors. The following Board approved share repurchase programs were executed through a combination of open market transactions and accelerated share repurchase (“ASR”) agreements (in millions):

| Board Approval Date |  | Amount Authorized |  | Shares Repurchased |  | Total Cash Utilized |  | Remaining Authorization |  | Authorization Completion Date
2022 Share Repurchase Program | Q4 FY 2021 |  | $ | 1,000 |  |  | 16.5 |  | $ | 1,000 |  |  | $ | — |  |  | Q2 FY 2023
2023 Share Repurchase Program | Q1 FY 2023 |  | $ | 1,000 |  |  | 2.7 |  | $ | 224 |  |  | (1) |  | Q4 FY 2023
Amended 2023 Share Repurchase Program(2) | Q1 FY 2024 |  | $ | 2,500 |  |  | 20.4 |  | $ | 2,500 |  |  | $ | — |  |  | Q1 FY 2025
2025 Share Repurchase Program(3) | Q1 FY 2025 |  | $ | 1,000 |  |  | 6.5 |  | $ | 972 |  |  | $ | 28 |  |  |

(1)In September 2023, the Board of Directors amended and increased the 2023 Share Repurchase Program to allow for the repurchase of up to $2.5 billion of the Company’s common stock.
(2)In September 2024, an ASR transaction was completed, and 1.0 million additional shares were delivered under the Q4 FY 2024 ASR agreements. As of November 30, 2024, no authorization remained under the amended 2023 Share Repurchase Program.
14

Table of Contents
(3)As of February 28, 2025, 4.3 million shares had been repurchased for $636 million and $364 million remained available under the 2025 Share Repurchase Program. As of April 3, 2025, 6.5 million shares had been repurchased for $972 million and $28 million remains available under the 2025 Share Repurchase Program.
Under ASR agreements, the Company makes payments to the participating financial institutions and receives an initial delivery of shares of common stock. The final number of shares delivered upon settlement of the ASR agreements is determined based on a discount to the volume weighted average price of the Company’s common stock during the term of the agreements. At the time the shares are received by the Company, the initial delivery and the final receipt of shares upon settlement of the ASR agreements results in an immediate reduction of the outstanding shares used to calculate the weighted-average common shares outstanding for basic and diluted earnings per share.
The terms of ASR agreements, structured as outlined above, were as follows (in millions, except average price):

Agreement Execution Date |  | Agreement Settlement Date |  | Agreement Amount |  | Initial Shares Delivered |  | Additional Shares Delivered |  | Total Shares Delivered |  | Average Price Paid Per Share |  |
Q1 FY 2024 |  | Q1 FY 2024 |  | $ | 500 |  |  | 3.3 |  | 0.6 |  | 3.9 |  | $ | 128.61 |  |  |
Q4 FY 2024 |  | Q1 FY 2025 |  | $ | 555 |  |  | 4.2 |  | 1.0 |  | 5.2 |  | $ | 107.08 |  |  |
Q2 FY 2025 |  | Q3 FY 2025 | (1) | $ | 310 |  |  | 1.8 |  | 0.2 |  | 2.0 |  | $ | 154.44 |  |  |
Q3 FY 2025 |  | Q4 FY 2025 |  | $ | 309 |  |  | 1.8 |  | (2) |  | (2) |  | $ | 135.99 |  |  |

(1)In December 2024, as part of the 2025 Share Repurchase Program, the Company entered into ASR agreements to repurchase $310 million, excluding excise tax, of the Company’s common stock. Under the ASR agreements, the Company made payments of $310 million to participating financial institutions and received an initial delivery of shares of common stock. In March 2025, the ASR transaction was completed, and 0.2 million additional shares were delivered under the Q2 FY 2025 ASR agreements.
(2)In March 2025, as part of the 2025 Share Repurchase Program, the Company entered into ASR agreements to repurchase $309 million, excluding excise tax, of the Company’s common stock. Under the ASR agreements, the Company made payments of $309 million to participating financial institutions and received an initial delivery of shares of common stock. The delivery of any remaining shares will occur at the final settlement of the transactions under the ASR agreements.
In addition, the Company repurchased shares of its common stock through the open market as follows (in millions):

|  | Three months ended |  | Six months ended
|  | February 28, 2025 |  | February 29, 2024 |  | February 28, 2025 |  | February 29, 2024
|  | Shares |  | Cost |  | Shares |  | Cost |  | Shares |  | Cost |  | Shares |  | Cost
Open market share repurchases(1) |  | 0.7 |  | $ | 94 |  |  | 6.5 |  | $ | 824 |  |  | 2.5 |  | $ | 326 |  |  | 6.5 |  | $ | 824 |

(1)As of April 3, 2025, 2.7 million shares had been repurchased for $353 million through open market transactions under the 2025 Share Repurchase Program.
Warrants
On December 27, 2024, the Company issued a warrant (the “Warrant”) to Amazon.com NV Investment Holdings LLC (“Warrantholder”) to acquire up to 1,158,539 ordinary shares of the Company (“Warrant Shares”) at an initial exercise price of $137.7671 per share, which is the preceding 30 trading day VWAP. The Warrant allows for cashless exercise and expires December 27, 2031. The Warrant Shares are subject to vesting for payments for purchased products and services over the seven-year Warrant term, with 59,582 of the Warrant Shares having vested upon issuance.
Upon the consummation of an acquisition transaction (as defined in the Warrant), subject to certain exceptions, the unvested portion of the Warrant will vest in full. So long as the Warrant is unexercised, the Warrant does not entitle the Warrantholder to any voting rights or any other common stockholder rights. The exercise price and the number of Warrant Shares are subject to customary anti-dilution adjustments.
15

Table of Contents
The Company accounts for the Warrant as an equity instrument within additional paid-in-capital at its estimated fair value on the Condensed Consolidated Balance Sheets, and the provision for common stock warrant is recorded as a reduction to revenue on the Condensed Consolidated Statements of Operations. To estimate the fair value of the Warrant, the Company used the Black-Scholes option pricing model, which is based on assumptions that require management to use judgement. Based on the estimated fair value, the Company determined the amount of provision for common stock warrant, which is amortized ratably as a reduction to revenue based on the Company’s estimate of revenue over the Warrant term.
The estimated fair value of the Warrant was determined as of the issuance date, using the Black-Scholes option pricing model. The following assumptions were used in the model:

| December 27, 2024
Stock price | $ | 145.92
Exercise price | $ | 137.77
Expected life | 7.0 years
Expected volatility(1) | 34.4 | %
Risk-free interest rate | 4.5 | %

(1)The expected volatility was estimated using the historical volatility derived from the Company’s common stock.
The following table summarizes the Warrant activity for the six months ended February 28, 2025:

| Warrant Shares
Outstanding as of August 31, 2024 | — |
Changes during the period |
Shares granted | 1,158,539 |
Shares vested | (59,582) |
Outstanding as of February 28, 2025 | 1,098,957 |
Exercisable as of February 28, 2025 | 59,582 |

13. Concentration of Risk and Segment Data
Concentration of Risk
Sales of the Company’s products are concentrated among specific customers. During the six months ended February 28, 2025, the Company’s five largest customers accounted for approximately 33% of its net revenue and 88 customers accounted for approximately 90% of its net revenue. Sales to these customers were reported in the Regulated Industries, Intelligent Infrastructure, and Connected Living and Digital Commerce operating segments.
The Company procures components from a broad group of suppliers. Some of the products manufactured by the Company require one or more components that are available from only a single source.
Segment Data
Operating segments are defined as components of an enterprise that engage in business activities from which they may earn revenues and incur expenses; for which separate financial information is available; and whose operating results are regularly reviewed by the chief operating decision maker (“CODM”) to assess the performance of the individual segment and make decisions about resources to be allocated to the segment.
The Company derives its revenue from providing comprehensive electronics design, production, and product management services. The CODM evaluates performance and allocates resources on a segment basis. Prior to the first quarter of fiscal year 2025, the Company’s operating segments consisted of two segments – Electronics Manufacturing Services (“EMS”) and Diversified Manufacturing Services (“DMS”). Beginning September 1, 2024, the Company reorganized its internal structure to focus on speed, precision, and solutions and, as a result of the organizational realignment, the Company’s operating segments now consist of three segments – Regulated Industries, Intelligent Infrastructure, and Connected Living and Digital Commerce, which are also the Company’s reportable segments. All prior period disclosures presented have been recast to reflect this change.
16

Table of Contents
The Regulated Industries segment is focused on regulated markets and includes revenues from customers primarily in the automotive and transportation, healthcare and packaging, and renewable energy infrastructure industries. The Intelligent Infrastructure segment is focused on the modern digital ecosystem including artificial intelligence (“AI”) infrastructure and includes revenues from customers primarily in the capital equipment, cloud and data center infrastructure, and networking and communications industries. The Connected Living and Digital Commerce segment is focused on digitalization and automation, including warehouse automation and robotics, and includes revenues from customers primarily in the connected living and digital commerce industries. The segments are organized based on the economic profiles of the services performed, including manufacturing capabilities, market strategy, margins, return on capital, and risk profiles.
Net revenue for the operating segments is attributed to the segment in which the service is performed. An operating segment’s performance is evaluated based on its pre-tax operating contribution, or segment income. Segment income is defined as net revenue less cost of revenue, segment selling, general and administrative expenses, segment research, and development expenses and an allocation of corporate manufacturing expenses and selling, general and administrative expenses. Certain items are excluded from the calculation of segment income. Total segment assets are defined as accounts receivable, contract assets, inventories, net, customer-related property, plant and equipment, intangible assets net of accumulated amortization, and goodwill. All other non-segment assets are reviewed on a global basis by management. Transactions between operating segments are generally recorded at amounts that approximate those at which we would transact with third parties.
The following table presents the Company’s revenues disaggregated by segment (in millions):

| Three months ended
| February 28, 2025 |  | February 29, 2024
| Point in time |  | Over time |  | Total |  | Point in time |  | Over time |  | Total
Regulated Industries | $ | 133 |  |  | $ | 2,608 |  |  | $ | 2,741 |  |  | $ | 114 |  |  | $ | 2,870 |  |  | $ | 2,984 |
Intelligent Infrastructure | 1,217 |  |  | 1,430 |  |  | 2,647 |  |  | 1,200 |  |  | 1,044 |  |  | 2,244 |
Connected Living and Digital Commerce(1) | 365 |  |  | 975 |  |  | 1,340 |  |  | 665 |  |  | 874 |  |  | 1,539 |
Total | $ | 1,715 |  |  | $ | 5,013 |  |  | $ | 6,728 |  |  | $ | 1,979 |  |  | $ | 4,788 |  |  | $ | 6,767 |
| Six months ended
| February 28, 2025 |  | February 29, 2024
| Point in time |  | Over time |  | Total |  | Point in time |  | Over time |  | Total
Regulated Industries | $ | 268 |  |  | $ | 5,430 |  |  | $ | 5,698 |  |  | $ | 246 |  |  | $ | 5,930 |  |  | $ | 6,176 |
Intelligent Infrastructure | 2,323 |  |  | 2,820 |  |  | 5,143 |  |  | 2,277 |  |  | 2,335 |  |  | 4,612 |
Connected Living and Digital Commerce(1) | 820 |  |  | 2,061 |  |  | 2,881 |  |  | 2,565 |  |  | 1,801 |  |  | 4,366 |
Total | $ | 3,411 |  |  | $ | 10,311 |  |  | $ | 13,722 |  |  | $ | 5,088 |  |  | $ | 10,066 |  |  | $ | 15,154 |

(1)Decrease in point in time revenues from the prior period is primarily driven by the divestiture of the Mobility Business during the three months ended February 29, 2024.
The Company operates in approximately 30 countries worldwide. Sales to unaffiliated customers are based on the Company location that maintains the customer relationship and transacts the external sale. The following table sets forth, for the periods indicated, foreign source revenue expressed as a percentage of net revenue:

| Three months ended |  | Six months ended(1)
| February 28, 2025 |  | February 29, 2024 |  | February 28, 2025 |  | February 29, 2024
Foreign source revenue | 77.0 | % |  | 82.5 | % |  | 78.9 | % |  | 84.7 | %

(1)Decrease from the prior period is primarily driven by the divestiture of the Mobility Business during the three months ended February 29, 2024.
17

Table of Contents
The following tables sets forth operating segment information (in millions):

| Three months ended |  | Six months ended
| February 28, 2025 |  | February 29, 2024 |  | February 28, 2025 |  | February 29, 2024
Segment income and reconciliation of income before income tax |  |  |  |  |  |  |
Regulated Industries | $ | 132 |  |  | $ | 138 |  |  | $ | 270 |  |  | $ | 286 |
Intelligent Infrastructure | 141 |  |  | 94 |  |  | 261 |  |  | 206 |
Connected Living and Digital Commerce | 61 |  | 106 |  |  | 150 |  |  | 345 |
Total segment income | $ | 334 |  |  | $ | 338 |  |  | $ | 681 |  |  | $ | 837 |
Reconciling items: |  |  |  |  |  |  |
Amortization of intangibles | (15) |  |  | (9) |  |  | (28) |  |  | (15) |
Stock-based compensation expense and related charges | (21) |  |  | (23) |  |  | (65) |  |  | (69) |
Restructuring, severance and related charges(1) | (45) |  |  | (70) |  |  | (128) |  |  | (197) |
Business interruption and impairment charges, net(2) | — |  |  | — |  |  | (9) |  |  | — |
Gain from the divestiture of businesses(3) | — |  |  | 944 |  |  | — |  |  | 944 |
Acquisition and divestiture related charges(3) | (8) |  |  | (46) |  |  | (8) |  |  | (61) |
Other expense (net of periodic benefit cost) | (24) |  |  | (25) |  |  | (45) |  |  | (48) |
Interest expense, net | (37) |  |  | (47) |  |  | (75) |  |  | (94) |
Income before income tax | $ | 184 |  |  | $ | 1,062 |  |  | $ | 323 |  |  | $ | 1,297 |

(1)Charges recorded during the three months and six months ended February 28, 2025, and February 29, 2024, primarily related to the 2025 Restructuring Plan and 2024 Restructuring Plan, respectively.
(2)Charges recorded during the six months ended February 28, 2025, relate primarily to costs associated with damage from Hurricanes Helene and Milton, which impacted our operations in St. Petersburg, Florida, and Asheville and Hendersonville, North Carolina.
(3)The Company completed the divestiture of the Mobility Business and recorded a pre-tax gain of $944 million, subject to certain post-closing adjustments that were realized in March 2025. The Company incurred transaction and disposal costs in connection with the sale of approximately $46 million and $61 million during the three months and six months ended February 29, 2024, respectively.

|  | February 28, 2025 |  | August 31, 2024
Total assets: |  |  |  |
Regulated Industries |  | $ | 6,103 |  |  | $ | 5,855 |
Intelligent Infrastructure |  | 3,219 |  |  | 2,624 |
Connected Living and Digital Commerce |  | 2,191 |  |  | 2,297 |
Other non-allocated assets |  | 5,883 |  |  | 6,575 |
Total |  | $ | 17,396 |  |  | $ | 17,351 |

18

Table of Contents
14. Restructuring, Severance, and Related Charges
Following is a summary of the Company’s restructuring, severance, and related charges (in millions):

| Three months ended |  | Six months ended
| February 28, 2025(1) |  | February 29, 2024(2) |  | February 28, 2025(1) |  | February 29, 2024(2)
Employee severance and benefit costs | $ | 18 |  |  | $ | 28 |  |  | $ | 45 |  |  | $ | 123 |
Lease costs | 1 |  |  | 1 |  |  | 4 |  |  | 1 |
Asset write-off costs | 4 |  |  | 33 |  |  | 27 |  |  | 55 |
Other costs | 22 |  |  | 8 |  |  | 52 |  |  | 18 |
Total restructuring, severance and related charges(3) | $ | 45 |  |  | $ | 70 |  |  | $ | 128 |  |  | $ | 197 |

(1)Primarily relates to the 2025 Restructuring Plan.
(2)Primarily relates to the 2024 Restructuring Plan.
(3)Except for asset write-off costs, all restructuring, severance and related charges are cash costs.
The following table presents the Company’s restructuring, severance, and related charges disaggregated by segment (in millions):

| Three months ended |  | Six months ended
| February 28, 2025 |  | February 29, 2024 |  | February 28, 2025 |  | February 29, 2024
Total restructuring, severance and related charges: |  |  |  |  |  |  |
Regulated Industries | $ | 3 |  |  | $ | 4 |  |  | $ | 24 |  |  | $ | 36 |
Intelligent Infrastructure | 21 |  |  | 11 |  |  | 50 |  |  | 40 |
Connected Living and Digital Commerce | (1) |  |  | 31 |  |  | 5 |  |  | 78 |
Non-allocated charges | 22 |  |  | 24 |  |  | 49 |  |  | 43 |
Total | $ | 45 |  |  | $ | 70 |  |  | $ | 128 |  |  | $ | 197 |

See Note 13 – “Concentration of Risk and Segment Data” to the Condensed Consolidated Financial Statements for further details on the change in reportable segments.
2025 Restructuring Plan
On September 24, 2024, the Company’s Board of Directors approved a restructuring plan to align our support infrastructure to further optimize organizational effectiveness. This action includes headcount reductions across our Selling, General, and Administrative (“SG&A”) and manufacturing cost base and capacity realignment (the “2025 Restructuring Plan”). The 2025 Restructuring Plan reflects the Company’s intention only and restructuring decisions, and the timing of such decisions, at certain locations are still subject to consultation with the Company’s employees and their representatives.
The Company currently expects to recognize approximately $150 million to $200 million in pre-tax restructuring and other related costs over the course of the Company’s 2025 fiscal year. The charges relating to the 2025 Restructuring Plan are currently expected to result in net cash expenditures of approximately $100 million to $130 million that will be payable over the course of the Company’s fiscal years 2025 and 2026. The exact timing of these charges and cash outflows, as well as the estimated cost ranges by category type, have not been finalized. This information will be subject to the finalization of timetables for the transition of functions, consultation with employees and their representatives as well as the statutory severance requirements of the jurisdictions impacted, and the amount and timing of the actual charges may vary due to a variety of factors. The Company’s estimates for the charges discussed above exclude any potential income tax effects.
19

Table of Contents
The table below summarizes the Company’s liability activity, primarily associated with the 2025 Restructuring Plan (in millions):

| Employee Severance and Benefit Costs |  | Lease Costs |  | Asset Write-off Costs |  | Other Related Costs |  | Total
Balance as of August 31, 2024 | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Restructuring related charges | 44 |  |  | 3 |  |  | 21 |  |  | 48 |  |  | 116 |
Asset write-off charge and other non-cash activity | — |  |  | — |  |  | (21) |  |  | (22) |  |  | (43) |
Cash payments | (28) |  |  | (3) |  |  | — |  |  | (8) |  |  | (39) |
Balance as of February 28, 2025 | $ | 16 |  |  | $ | — |  |  | $ | — |  |  | $ | 18 |  |  | $ | 34 |

2024 Restructuring Plan
On September 26, 2023, the Company’s Board of Directors approved a restructuring plan to (i) realign the Company’s cost base for stranded costs associated with the Company’s sale and realignment of the Mobility Business and (ii) optimize the Company’s global footprint. This action includes headcount reductions across our SG&A cost base and capacity realignment (the “2024 Restructuring Plan”).
The 2024 Restructuring Plan, totaling approximately $300 million in pre-tax restructuring and other related costs, was substantially complete as of August 31, 2024.
The table below summarizes the Company’s liability activity, primarily associated with the 2024 Restructuring Plan (in millions):

| Employee Severance and Benefit Costs |  | Lease Costs |  | Asset Write-off Costs |  | Other Related Costs |  | Total
Balance as of August 31, 2024 | $ | 66 |  |  | $ | 1 |  |  | $ | — |  |  | $ | 5 |  |  | $ | 72 |
Restructuring related charges | 1 |  |  | 1 |  |  | 6 |  |  | 4 |  |  | 12 |
Asset write-off charge and other non-cash activity | — |  |  | — |  |  | (6) |  |  | — |  |  | (6) |
Cash payments | (44) |  |  | — |  |  | — |  |  | (6) |  |  | (50) |
Balance as of February 28, 2025 | $ | 23 |  |  | $ | 2 |  |  | $ | — |  |  | $ | 3 |  |  | $ | 28 |

15. Income Taxes
Effective Income Tax Rate
The U.S. federal statutory income tax rate and the Company's effective income tax rate are as follows:

| Three months ended |  | Six months ended
| February 28, 2025 |  | February 29, 2024 |  | February 28, 2025 |  | February 29, 2024
U.S. federal statutory income tax rate | 21.0 | % |  | 21.0 | % |  | 21.0 | % |  | 21.0 | %
Effective income tax rate | 36.2 | % |  | 12.7 | % |  | 32.7 | % |  | 13.6 | %

The effective income tax rate differed for the three months and six months ended February 28, 2025, compared to the three months and six months ended February 29, 2024, primarily due to: (i) a change in the jurisdictional mix of earnings, driven in part by decreased income before income taxes in low tax rate jurisdictions for the three months and six months ended February 28, 2025, (ii) an $18 million income tax benefit for the reversal of an unrecognized tax benefit due to a lapse of statute for the six months ended February 28, 2025, and (iii) the gain from the divestiture of the Mobility Business and corresponding $58 million of income tax expense during the three months ended February 29, 2024.
20

Table of Contents
The effective income tax rate differed from the U.S. federal statutory income tax rate of 21.0% during the three months and six months ended February 28, 2025 and February 29, 2024, primarily due to: (i) the jurisdictional mix of earnings, (ii) losses in tax jurisdictions with existing valuation allowances, (iii) an $18 million income tax benefit for the reversal of an unrecognized tax benefit due to a lapse of statute for the six months ended February 28, 2025, (iv) tax incentives granted to sites in China, Malaysia, Singapore, and Vietnam for the three months and six months ended February 29, 2024, and (v) the gain from the divestiture of the Mobility Business and corresponding $58 million of income tax expense during the three months ended February 29, 2024.
16. Earnings Per Share and Dividends
Earnings Per Share
The Company calculates its basic earnings per share by dividing net income attributable to the Company by the weighted average number of common shares outstanding during the period. The Company’s diluted earnings per share is calculated in a similar manner but includes the effect of dilutive securities. The difference between the weighted average number of basic shares outstanding and the weighted average number of diluted shares outstanding is primarily due to dilutive unvested restricted stock units.
Potential shares of common stock are excluded from the computation of diluted earnings per share when their effect would be antidilutive. Performance-based restricted stock units are considered dilutive when the related performance criteria have been met assuming the end of the reporting period represents the end of the performance period. All potential shares of common stock are antidilutive in periods of net loss. Potential shares of common stock not included in the computation of earnings per share because their effect would have been antidilutive or because the performance criterion was not met were as follows (in thousands):

| Three months ended |  | Six months ended
| February 28, 2025 |  | February 29, 2024 |  | February 28, 2025 |  | February 29, 2024
Restricted stock units | 334.3 |  |  | 293.5 |  |  | 334.3 |  |  | 309.5 |

Dividends
The following table sets forth cash dividends declared by the Company to common stockholders during the six months ended February 28, 2025, and February 29, 2024 (in millions, except for per share data):

| Dividend Declaration Date |  | Dividend per Share |  | Total of Cash Dividends Declared |  | Date of Record for Dividend Payment |  | Dividend Cash Payment Date
Fiscal Year 2025: | October 17, 2024 |  | $ | 0.08 |  |  | $ | 9 |  |  | November 15, 2024 |  | December 3, 2024
| January 23, 2025 |  | $ | 0.08 |  |  | $ | 8 |  |  | February 18, 2025 |  | March 4, 2025
Fiscal Year 2024: | October 19, 2023 |  | $ | 0.08 |  |  | $ | 11 |  |  | November 15, 2023 |  | December 4, 2023
| January 25, 2024 |  | $ | 0.08 |  |  | $ | 10 |  |  | February 15, 2024 |  | March 4, 2024

17. Business Acquisitions and Divestitures
Acquisitions
Fiscal Year 2025
On February 3, 2025, the Company completed the acquisition of Pharmaceutics International, Inc. (“Pii”) for cash consideration transferred of $307 million. The final purchase price is subject to adjustment based on certain customary conditions as outlined in the purchase agreement. Pii is a contract development and manufacturing organization specializing in early stage, clinical, and commercial volume aseptic filling, lyophilization, and oral solid dose manufacturing. The acquisition will enhance the Company’s existing Regulated Industries service offerings, which includes the development and commercial production of auto-injectors, pen injectors, inhalers, and on-body pumps.
21

Table of Contents
The acquisition of Pii was accounted for as a business combination using the acquisition method of accounting. Assets acquired of $349 million, including $149 million in intangible assets and $132 million in goodwill, and liabilities assumed of $42 million were recorded at their estimated fair values as of the acquisition date. The preliminary estimates and measurements are subject to change during the measurement period for assets acquired, liabilities assumed, and tax adjustments. The excess of the purchase price over the fair value of the acquired assets and assumed liabilities was recorded to goodwill and was fully allocated to the Regulated Industries segment. Goodwill is primarily attributable to expected synergies enabling comprehensive support for customers in drug development, clinical trials, and product commercialization at scale. The majority of the goodwill is currently not expected to be deductible for income tax purposes. The results of operations were included in the Company’s condensed consolidated financial results beginning on February 3, 2025. Pro forma information has not been provided as the acquisition of Pii is not deemed to be significant.
On October 1, 2024, the Company completed the acquisition of Mikros Technologies LLC (“Mikros Technologies”) for consideration transferred of $63 million. Mikros Technologies is a leader in the engineering and manufacturing of liquid cooling solutions for thermal management. The final purchase price is subject to adjustment based on certain customary conditions as outlined in the purchase agreement.
The acquisition of Mikros Technologies was accounted for as a business combination using the acquisition method of accounting. Assets acquired of $63 million, including $40 million in intangible assets and $17 million in goodwill, were recorded at their estimated fair values as of the acquisition date. The preliminary estimates and measurements are subject to change during the measurement period for assets acquired, liabilities assumed, and tax adjustments. The excess of the purchase price over the fair value of the acquired assets and assumed liabilities was recorded to goodwill and was fully allocated to the Intelligent Infrastructure segment. The majority of the goodwill is currently expected to be deductible for income tax purposes. The results of operations were included in the Company’s condensed consolidated financial results beginning on October 1, 2024. Pro forma information has not been provided as the acquisition of Mikros Technologies is not deemed to be significant.
Fiscal Year 2024
On November 1, 2023, the Company completed the acquisition of ProcureAbility Inc. (“ProcureAbility”) for approximately $60 million in cash. ProcureAbility is a procurement services provider specializing in technology-enabled advisory, managed services, digital, staffing, and recruiting solutions.
The acquisition of ProcureAbility was accounted for as a business combination using the acquisition method of accounting. Assets acquired of $87 million, including $40 million in intangible assets and $38 million in goodwill, and liabilities assumed of $26 million were recorded at their estimated fair values as of the acquisition date. The excess of the purchase price over the fair value of the acquired assets and assumed liabilities was recorded to goodwill and was fully allocated to the Regulated Industries segment. The majority of the goodwill is currently not expected to be deductible for income tax purposes. The results of operations were included in the Company’s condensed consolidated financial results beginning on November 1, 2023. Pro forma information has not been provided as the acquisition of ProcureAbility is not deemed to be significant.
Divestitures
Fiscal Year 2024
The Company announced on September 26, 2023, that, through our indirect subsidiary, Jabil Circuit (Singapore) Pte. Ltd., a Singapore private limited company (“Singapore Seller”), we agreed to sell to an affiliate of BYD Electronic (International) Co. Ltd., a Hong Kong limited liability company (“Purchaser” or “BYDE”), its product manufacturing business in Chengdu, including its supporting component manufacturing in Wuxi, the Mobility Business, for cash consideration of approximately $2.2 billion, subject to certain customary purchase price adjustments.
As of August 31, 2023, the Company determined the Mobility Business met the criteria to be classified as held for sale. Assets and liabilities classified as held for sale had a carrying value less than the estimated fair value less cost to sell and, thus, no adjustment to the carrying value of the disposal group was necessary. Depreciation and amortization expense for long-lived assets was not recorded for the period in which these assets were classified as held for sale. The divestiture did not meet the criteria to be reported as discontinued operations, and the Company continued to report the operating results for the Mobility Business in the Company’s Condensed Consolidated Statement of Operations in the DMS segment until the Closing Date.
22

Table of Contents
On December 29, 2023, the Closing Date, the Company completed the sale of the Mobility Business. As a result of the transaction, the Company derecognized net assets of approximately $1.2 billion, and recorded a pre-tax gain of $942 million in the fiscal year ended August 31, 2024. Certain post-closing adjustments were realized in March 2025, which will result in recognition of a $54 million pre-tax gain during the three months ended May 31, 2025. In addition, the Company agreed to indemnify BYDE from certain liabilities that may arise post-close that relate to periods prior to the Closing Date. The Company incurred transaction and disposal costs in connection with the sale of approximately $67 million during the fiscal year ended August 31, 2024, which are included in continuing operations in the Company’s Condensed Consolidated Statements of Operations.
18. Fair Value Measurements
Fair Value Measurements on a Recurring Basis
The following table presents the fair value of the Company's financial assets and liabilities measured at fair value by hierarchy level on a recurring basis as of the periods indicated (in millions):

| Fair Value Hierarchy |  | February 28, 2025 |  | August 31, 2024
Assets: |  |  |  |  |
Cash and cash equivalents: |  |  |  |  |
Cash equivalents | Level 1 | (1) | $ | 243 |  |  | $ | 303 |
Prepaid expenses and other current assets: |  |  |  |  |
Short-term investments | Level 1 |  | 26 |  |  | 27 |
Forward foreign exchange contracts: |  |  |  |  |
Derivatives designated as hedging instruments (Note 10) | Level 2 | (2) | 5 |  |  | 11 |
Derivatives not designated as hedging instruments (Note 10) | Level 2 | (2) | 6 |  |  | 25 |
Net investment hedges: |  |  |  |  |
Derivatives designated as hedging instruments (Note 10) | Level 2 | (2) | 9 |  |  | — |
Other assets: |  |  |  |  |
Net investment hedges: |  |  |  |  |
Derivatives designated as hedging instruments (Note 10) | Level 2 | (2) | 1 |  |  | — |
Liabilities: |  |  |  |  |
Accrued expenses: |  |  |  |  |
Forward foreign exchange contracts: |  |  |  |  |
Derivatives designated as hedging instruments (Note 10) | Level 2 | (2) | $ | 7 |  |  | $ | 28 |
Derivatives not designated as hedging instruments (Note 10) | Level 2 | (2) | 23 |  |  | 22 |
Net investment hedges: |  |  |  |  |
Derivatives designated as hedging instruments (Note 10) | Level 2 | (2) | — |  |  | 6 |
Other liabilities: |  |  |  |  |
Net investment hedges: |  |  |  |  |
Derivatives designated as hedging instruments (Note 10) | Level 2 | (2) | — |  |  | 5 |

(1)Consist of time deposits that are readily convertible to cash with original maturities of 90 days or less.
(2)The Company’s forward foreign exchange contracts, including cash flow hedges and net investment hedges are measured on a recurring basis at fair value, based on foreign currency spot rates and forward rates quoted by banks or foreign currency dealers.
Fair Value of Financial Instruments
The carrying amounts of cash and cash equivalents, trade accounts receivable, prepaid expenses, and other current assets, accounts payable and accrued expenses approximate fair value because of the short-term nature of these financial instruments. The carrying amounts of borrowings under credit facilities and under loans approximate fair value as interest rates on these instruments approximate current market rates.
23

Table of Contents
Notes payable and long-term debt is carried at amortized cost; however, the Company estimates the fair values of notes payable and long-term debt for disclosure purposes. The following table presents the carrying amounts and fair values of the Company's notes payable and long-term debt, by hierarchy level as of the periods indicated (in millions):

|  |  |  | February 28, 2025 |  | August 31, 2024
|  | Fair Value Hierarchy |  | Carrying Amount |  | Fair Value |  | Carrying Amount |  | Fair Value
Notes payable and long-term debt: (Note 6) |  |  |  |  |  |  |  |  |  |
3.950% Senior Notes |  | Level 2 | (1) | $ | 498 |  |  | $ | 489 |  |  | $ | 498 |  |  | $ | 487 |
3.600% Senior Notes |  | Level 2 | (1) | $ | 497 |  |  | $ | 470 |  |  | $ | 497 |  |  | $ | 468 |
3.000% Senior Notes |  | Level 2 | (1) | $ | 595 |  |  | $ | 538 |  |  | $ | 594 |  |  | $ | 529 |
1.700% Senior Notes |  | Level 2 | (1) | $ | 499 |  |  | $ | 484 |  |  | $ | 499 |  |  | $ | 476 |
4.250% Senior Notes |  | Level 2 | (1) | $ | 497 |  |  | $ | 496 |  |  | $ | 496 |  |  | $ | 495 |
5.450% Senior Notes |  | Level 2 | (1) | $ | 297 |  |  | $ | 306 |  |  | $ | 296 |  |  | $ | 306 |

(1)The fair value estimates are based upon observable market data.
19. Commitments and Contingencies
Legal Proceedings
The Company is party to certain lawsuits in the ordinary course of business. The Company does not believe that these proceedings, individually or in the aggregate, will have a material adverse effect on the Company’s financial position, results of operations or cash flows.
20. New Accounting Guidance
New accounting guidance adopted during the period did not have a material impact to the Company.
Recently issued accounting guidance is not applicable or did not have, or is not expected to have, a material impact to the Company.
24

Table of Contents
JABIL INC. AND SUBSIDIARIES
This Quarterly Report on Form 10-Q contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that involve risks and uncertainties. Many of the forward-looking statements are located in Item 2 of this Form 10-Q under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Forward-looking statements can also be identified by words such as “future,” “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “will,” “would,” “should,” “could,” “can,” “may,” and similar terms. Forward-looking statements are not guarantees of future performance and the Company’s actual results may differ significantly from the results discussed in the forward-looking statements. Achievement of anticipated results is subject to substantial risks, uncertainties and inaccurate assumptions. Should these risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results could vary materially from past results and those anticipated, estimated or projected. You should bear this in mind as you consider forward-looking statements, and you are cautioned not to put undue reliance on forward-looking statements. We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law or by the rules and regulations of the SEC. You are advised, however, to consult any further disclosures we make on related subjects. Factors that might cause such differences include, but are not limited to, those discussed in Part II, Item 1A to this Quarterly Report on Form 10-Q and in Part 1, Item 1A of the Company’s Annual Report on Form 10-K for the year ended August 31, 2024 such as, scheduling production, managing growth and capital expenditures and maximizing the efficiency of our manufacturing capacity effectively; managing rapid declines or increases in customer demand and other related customer challenges that may occur; our dependence on a limited number of customers; our ability to purchase components efficiently and reliance on a limited number of suppliers for critical components; risks arising from relationships with emerging companies; changes in technology and competition in our industry; our ability to introduce new business models or programs requiring implementation of new competencies; competition; transportation issues; our ability to maintain our engineering, technological and manufacturing expertise; retaining key personnel; risks associated with international sales and operations, including geopolitical uncertainties and trade disputes that have resulted in tariffs and other protectionist measures and could result in further such actions in the future; energy price increases or shortages; our ability to achieve expected profitability from acquisitions; risk arising from our restructuring activities; issues involving our information systems, including security issues; regulatory risks (including the expense of complying, or failing to comply, with applicable regulations; risk arising from design or manufacturing defects; risk arising from compliance, or failure to comply, with environmental, health and safety laws or regulations, risks arising from litigation and intellectual property risk); financial risks (including customers or suppliers who become financially troubled; turmoil in financial markets; tax risks; credit rating risks; risks of exposure to debt; currency fluctuations; and asset impairment); changes in financial accounting standards or policies; risk of natural disaster, climate change or other global events; and risks arising from expectations relating to environmental, social and governance considerations. References in this report to “the Company,” “Jabil,” “we,” “our,” or “us” mean Jabil Inc. together with its consolidated subsidiaries, except where the context otherwise requires.
25

Table of Contents

Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations

Overview
We are one of the leading providers of worldwide manufacturing services and solutions. We provide comprehensive electronics design, production, and product management services to companies in various industries and end markets. Our services enable our customers to reduce manufacturing costs, improve supply-chain management, reduce inventory obsolescence, lower transportation costs, and reduce product fulfillment time. Our manufacturing and supply chain management services and solutions include innovation, design, planning, fabrication and assembly, delivery, and managing the flow of resources and products. We derive substantially all of our revenue from production and product management services (collectively referred to as “manufacturing services”), which encompass the act of producing tangible components that are built to customer specifications and are then provided to the customer.
We serve our customers primarily through dedicated business units that combine highly automated, continuous flow manufacturing with advanced electronic design and design for manufacturability. We currently depend, and expect to continue to depend for the foreseeable future, upon a relatively small number of customers for a significant percentage of our net revenue, which in turn depends upon their growth, viability, and financial stability.
We conduct our operations in facilities that are located worldwide, including but not limited to, China, Mexico, Singapore, Malaysia, and the United States. We derived a substantial majority, 77.0% and 78.9% of net revenue, from our international operations for the three months and six months ended February 28, 2025, respectively. Our global manufacturing production sites allow customers to manufacture products simultaneously in the optimal locations for their products. Our global presence is key to assessing and executing on our business opportunities.
As of September 1, 2024, we are reporting our business in the following three segments: Regulated Industries, Intelligent Infrastructure, and Connected Living and Digital Commerce, which are also the Company’s reportable segments. Our Regulated Industries segment is focused on regulated markets and includes revenues from customers primarily in the automotive and transportation, healthcare and packaging, and renewable energy infrastructure industries. Our Intelligent Infrastructure segment is focused on the modern digital ecosystem including artificial intelligence (“AI”) infrastructure and includes revenues from customers primarily in the capital equipment, cloud and data center infrastructure, and networking and communications industries. Our Connected Living and Digital Commerce segment is focused on digitalization and automation, including warehouse automation and robotics, and includes revenues from customers primarily in the connected living and digital commerce industries.
We monitor the current economic environment and its potential impact on both the customers we serve as well as our end-markets and closely manage our costs and capital resources so that we can respond appropriately as circumstances change.
Refer to Item 7. “Management's Discussion and Analysis of Financial Condition and Results of Operations” section contained in our Annual Report on Form 10-K for the fiscal year ended August 31, 2024, for further discussion of the items disclosed in Item 2. “Management's Discussion and Analysis of Financial Condition and Results of Operations” section as of February 28, 2025, contained herein.
Summary of Results
The following table sets forth, for the periods indicated, certain key operating results and other financial information (in millions, except per share data):

| Three months ended |  | Six months ended
| February 28, 2025 |  | February 29, 2024 |  | February 28, 2025 |  | February 29, 2024
Net revenue | $ | 6,728 |  |  | $ | 6,767 |  |  | $ | 13,722 |  |  | $ | 15,154 |
Gross profit | $ | 576 |  |  | $ | 630 |  |  | $ | 1,182 |  |  | $ | 1,405 |
Operating income | $ | 245 |  |  | $ | 1,131 |  |  | $ | 442 |  |  | $ | 1,434 |
Net income attributable to Jabil Inc. | $ | 117 |  |  | $ | 927 |  |  | $ | 217 |  |  | $ | 1,121 |
Earnings per share – basic | $ | 1.07 |  |  | $ | 7.41 |  |  | $ | 1.95 |  |  | $ | 8.80 |
Earnings per share – diluted | $ | 1.06 |  |  | $ | 7.31 |  |  | $ | 1.93 |  |  | $ | 8.66 |

26

Table of Contents
Key Performance Indicators
Management regularly reviews financial and non-financial performance indicators to assess the Company’s operating results. Changes in our operating assets and liabilities are largely affected by our working capital requirements, which are dependent on the effective management of our sales cycle as well as timing of payments. Our sales cycle measures how quickly we can convert our manufacturing services into cash through sales. We believe the metrics set forth below are useful to investors in measuring our liquidity as future liquidity needs will depend on fluctuations in levels of inventory, accounts receivable, and accounts payable.
The following table sets forth, for the quarterly periods indicated, certain of management’s key financial performance indicators:

| Three months ended
| February 28, 2025 |  | November 30, 2024 |  | February 29, 2024
Sales cycle(1) | 33 days |  | 27 days |  | 48 days
Inventory turns (annualized)(2) | 4 turns |  | 5 turns |  | 4 turns
Days in accounts receivable(3) | 50 days |  | 48 days |  | 35 days
Days in inventory(4) | 80 days |  | 76 days |  | 87 days
Days in accounts payable(5) | 97 days |  | 97 days |  | 74 days

(1)The sales cycle is calculated as the sum of days in accounts receivable and days in inventory, less the days in accounts payable; accordingly, the variance in the sales cycle quarter over quarter was a direct result of changes in these indicators.
(2)Inventory turns (annualized) are calculated as 360 days divided by days in inventory.
(3)Days in accounts receivable is calculated as accounts receivable, net, divided by net revenue multiplied by 90 days. During the three months ended February 28, 2025, the increase in days in accounts receivable from the prior sequential quarter and the three months ended February 29, 2024, was primarily driven by timing of payments.
(4)Days in inventory is calculated as inventories, net and contract assets divided by cost of revenue multiplied by 90 days. During the three months ended February 28, 2025, the increase in days in inventory from the prior sequential quarter was primarily driven by the timing of sales. During the three months ended February 28, 2025, the decrease in days in inventory from the three months ended February 29, 2024, was primarily driven by higher consumption of inventory to support sales during the quarter and improved working capital management.
(5)Days in accounts payable is calculated as accounts payable divided by cost of revenue multiplied by 90 days. During the three months ended February 28, 2025, the increase in days in accounts payable from the three months ended February 29, 2024, was primarily due to higher purchases of customer-controlled consignment components and timing of cash payments.
Critical Accounting Policies and Estimates
The preparation of our Condensed Consolidated Financial Statements and related disclosures in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make estimates and judgments that affect our reported amounts of assets and liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates and assumptions based upon historical experience and various other factors and circumstances. Management believes that our estimates and assumptions are reasonable under the circumstances; however, actual results may vary from these estimates and assumptions under different future circumstances. For further discussion of our significant accounting policies, refer to Note 1 — “Description of Business and Summary of Significant Accounting Policies” to the Consolidated Financial Statements and “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies and Estimates” in our Annual Report on Form 10-K for the fiscal year ended August 31, 2024.
Recent Accounting Pronouncements
See Note 20 – “New Accounting Guidance” to the Condensed Consolidated Financial Statements for a discussion of recent accounting guidance.
27

Table of Contents
Results of Operations
Net Revenue
Generally, we assess revenue on a global customer basis regardless of whether the growth is associated with organic growth or as a result of an acquisition. Accordingly, we do not differentiate or separately report revenue increases generated by acquisitions as opposed to existing business. In addition, the added cost structures associated with our acquisitions have historically been relatively insignificant when compared to our overall cost structure.
The distribution of revenue across our segments has fluctuated, and will continue to fluctuate, as a result of numerous factors, including the following: fluctuations in customer demand; efforts to diversify certain portions of our business; business growth from new and existing customers; specific product performance; and any potential termination, or substantial winding down, of significant customer relationships.
As discussed in the “Overview” section, as of September 1, 2024, we are reporting our business in the following three segments – Regulated Industries, Intelligent Infrastructure, and Connected Living and Digital Commerce. In conjunction with this reorganization, there have been certain reclassifications made within the reported segments.

| Three months ended |  |  |  | Six months ended |  |
(dollars in millions) | February 28, 2025 |  | February 29, 2024 |  | Change |  | February 28, 2025 |  | February 29, 2024 |  | Change
Net revenue | $ | 6,728 |  |  | $ | 6,767 |  |  | (0.6) | % |  | $ | 13,722 |  |  | $ | 15,154 |  |  | (9.4) | %

Net revenue decreased during the three months ended February 28, 2025, compared to the three months ended February 29, 2024. Specifically, the Connected Living and Digital Commerce segment net revenue decreased 13% due to an 18% decrease in revenues primarily driven by the divestiture of the Mobility Business within our connected living business. The decrease is partially offset by a 5% increase in revenues from existing customers within our digital commerce business. The Regulated Industries segment net revenue decreased 8% primarily due to: (i) a 5% decrease in revenues from existing customers within our automotive and transportation business and (ii) a 3% decrease in revenues from existing customers within our healthcare and packaging business. The Intelligent Infrastructure segment net revenue increased 18% primarily due to: (i) a 19% increase in revenues from existing customers within our cloud and data center infrastructure business and (ii) a 9% increase in revenues from existing customers within our capital equipment business. The increase is partially offset by a 10% decrease in revenues from existing customers within our networking and communications business.
Net revenue decreased during the six months ended February 28, 2025, compared to the six months ended February 29, 2024. Specifically, the Connected Living and Digital Commerce segment net revenue decreased 34% due to a 38% decrease in revenues primarily driven by the divestiture of the Mobility Business within our connected living business. The decrease is partially offset by a 4% increase in revenues from existing customers within our digital commerce business. The Regulated Industries segment net revenue decreased 8% primarily due to: (i) a 4% decrease in revenues from existing customers within our renewable energy infrastructure business, (ii) a 3% decrease in revenues from existing customers within our automotive and transportation business, and (iii) a 1% decrease in revenues from existing customers within our healthcare and packaging business. The Intelligent Infrastructure segment net revenue increased 12% primarily due to: (i) a 16% increase in revenues from existing customers within our cloud and data center infrastructure business and (ii) a 8% increase in revenues from existing customers within our capital equipment business. The increase is partially offset by a 12% decrease in revenues from existing customers within our networking and communications business.
The following table sets forth, for the periods indicated, revenue by segment expressed as a percentage of net revenue:

| Three months ended |  | Six months ended
| February 28, 2025 |  | February 29, 2024 |  | February 28, 2025 |  | February 29, 2024
Regulated Industries | 41 | % |  | 44 | % |  | 42 | % |  | 41 | %
Intelligent Infrastructure | 39 | % |  | 33 | % |  | 37 | % |  | 30 | %
Connected Living and Digital Commerce | 20 | % |  | 23 | % |  | 21 | % |  | 29 | %
Total | 100 | % |  | 100 | % |  | 100 | % |  | 100 | %

28

Table of Contents
The following table sets forth, for the periods indicated, foreign source revenue expressed as a percentage of net revenue:

| Three months ended |  | Six months ended(1)
| February 28, 2025 |  | February 29, 2024 |  | February 28, 2025 |  | February 29, 2024
Foreign source revenue | 77.0 | % |  | 82.5 | % |  | 78.9 | % |  | 84.7 | %

(1)Decrease from the prior period is primarily driven by the divestiture of the Mobility Business during the three months ended February 29, 2024.
Gross Profit

| Three months ended |  | Six months ended
(dollars in millions) | February 28, 2025 |  | February 29, 2024 |  | February 28, 2025 |  | February 29, 2024
Gross profit | $ | 576 |  |  | $ | 630 |  |  | $ | 1,182 |  |  | $ | 1,405 |
Percent of net revenue | 8.6 | % |  | 9.3 | % |  | 8.6 | % |  | 9.3 | %

Gross profit as a percentage of net revenue decreased for the three months and six months ended February 28, 2025, compared to the three months and six months ended February 29, 2024, primarily due to product mix in our Connected Living and Digital Commerce segment.
Selling, General and Administrative

| Three months ended |  |  |  | Six months ended |  |
(in millions) | February 28, 2025 |  | February 29, 2024 |  | Change |  | February 28, 2025 |  | February 29, 2024 |  | Change
Selling, general and administrative | $ | 256 |  |  | $ | 308 |  |  | $ | (52) |  |  | $ | 561 |  |  | $ | 622 |  |  | $ | (61) |

Selling, general and administrative expenses decreased during the three months and six months ended February 28, 2025, compared to the three months and six months ended February 29, 2024, primarily due to a decrease in salary and salary related expenses.
Research and Development

| Three months ended |  | Six months ended
(dollars in millions) | February 28, 2025 |  | February 29, 2024 |  | February 28, 2025 |  | February 29, 2024
Research and development | $ | 7 |  |  | $ | 10 |  |  | $ | 15 |  |  | $ | 20 |
Percent of net revenue | 0.1 | % |  | 0.1 | % |  | 0.1 | % |  | 0.1 | %

Research and development expenses remained consistent as a percentage of net revenue during the three months and six months ended February 28, 2025, compared to the three months and six months ended February 29, 2024.
Amortization of Intangibles

| Three months ended |  |  |  | Six months ended |  |
(in millions) | February 28, 2025 |  | February 29, 2024 |  | Change |  | February 28, 2025 |  | February 29, 2024 |  | Change
Amortization of intangibles | $ | 15 |  |  | $ | 9 |  |  | $ | 6 |  |  | $ | 28 |  |  | $ | 15 |  |  | $ | 13 |

Amortization of intangibles increased during the three months and six months ended February 28, 2025, compared to the three months and six months ended February 29, 2024, primarily due to (i) amortization related to the Green Point trade name, which was reclassified to a definite-lived intangible asset during fiscal year 2024 and (ii) additional amortization associated with intangible assets related to the acquisitions of Mikros Technologies LLC and Pharmaceutics International, Inc. that occurred during the first and second quarters of fiscal year 2025.
29

Table of Contents
Restructuring, Severance and Related Charges

| Three months ended |  |  |  | Six months ended |  |
(in millions) | February 28, 2025 |  | February 29, 2024 |  | Change |  | February 28, 2025 |  | February 29, 2024 |  | Change
Restructuring, severance and related charges | $ | 45 |  |  | $ | 70 |  |  | $ | (25) |  |  | $ | 128 |  |  | $ | 197 |  |  | $ | (69) |

Restructuring, severance, and related charges decreased during the three months and six months ended February 28, 2025, compared to the three months and six months ended February 29, 2024, primarily due to higher restructuring, severance and related charges, related to the 2024 Restructuring Plan, during the three months and six months ended February 29, 2024. The decrease is partially offset by increased restructuring, severance and related charges, related to the 2025 Restructuring Plan, during the three months and six months ended February 28, 2025.
2025 Restructuring Plan
On September 24, 2024, our Board of Directors approved a restructuring plan to align our support infrastructure to further optimize organizational effectiveness. This action includes headcount reductions across our Selling, General and Administrative (“SG&A”) and manufacturing cost base and capacity realignment (the “2025 Restructuring Plan”). The 2025 Restructuring Plan reflects our intention only and restructuring decisions, including the timing of such decisions, at certain locations remain subject to consultation with the Company’s employees and their representatives.
We currently expect to recognize approximately $150 million to $200 million in pre-tax restructuring and other related costs over the course of our 2025 fiscal year. The charges relating to the 2025 Restructuring Plan are currently expected to result in net cash expenditures of approximately $100 million to $130 million that will be payable over the course of our fiscal years 2025 and 2026. The exact timing of these charges and cash outflows, as well as the estimated cost ranges by category type, have not been finalized. This information will be subject to the finalization of timetables for the transition of functions, consultation with employees and their representatives as well as the statutory severance requirements of the jurisdictions impacted, and the amount and timing of the actual charges may vary due to a variety of factors. Our estimates for the charges discussed above exclude any potential income tax effects.
2024 Restructuring Plan
On September 26, 2023, our Board of Directors approved a restructuring plan to (i) realign our cost base for stranded costs associated with the sale and realignment of the Mobility Business and (ii) optimize our global footprint. This action includes headcount reductions across our SG&A cost base and capacity realignment (the “2024 Restructuring Plan”).
The 2024 Restructuring Plan, totaling approximately $300 million in pre-tax restructuring and other related costs, was substantially complete as of August 31, 2024.
See Note 14 – “Restructuring, Severance and Related Charges” to the Condensed Consolidated Financial Statements for further discussion of restructuring, severance and related charges.
Gain from the Divestiture of Businesses

| Three months ended |  |  |  | Six months ended |  |
(in millions) | February 28, 2025 |  | February 29, 2024 |  | Change |  | February 28, 2025 |  | February 29, 2024 |  | Change
Gain from the divestiture of businesses | $ | — |  |  | $ | (944) |  |  | $ | 944 |  |  | $ | — |  |  | $ | (944) |  |  | $ | 944 |

In the second quarter of fiscal year 2024, we completed the divestiture of the Mobility Business and recorded a pre-tax gain of $944 million. Certain post-closing adjustments were realized in March 2025, which will result in recognition of a $54 million pre-tax gain during the three months ended May 31, 2025.
See Note 17 – “Business Acquisitions and Divestitures” to the Condensed Consolidated Financial Statements for additional information.
30

Table of Contents
Acquisition and Divestiture Related Charges

| Three months ended |  |  |  | Six months ended |  |
(in millions) | February 28, 2025 |  | February 29, 2024 |  | Change |  | February 28, 2025 |  | February 29, 2024 |  | Change
Acquisition and divestiture related charges | $ | 8 |  |  | $ | 46 |  |  | $ | (38) |  |  | $ | 8 |  |  | $ | 61 |  |  | $ | (53) |

Acquisition and divestiture related charges decreased during the three months and six months ended February 28, 2025, compared to the three months and six months ended February 29, 2024, primarily due to transaction and disposal costs incurred in connection with the divestiture of the Mobility Business during fiscal year 2024.
See Note 17 – “Business Acquisitions and Divestitures” to the Condensed Consolidated Financial Statements for additional information.
Other Expense

| Three months ended |  |  |  | Six months ended |  |
(in millions) | February 28, 2025 |  | February 29, 2024 |  | Change |  | February 28, 2025 |  | February 29, 2024 |  | Change
Other expense | $ | 24 |  |  | $ | 22 |  |  | $ | 2 |  |  | $ | 44 |  |  | $ | 43 |  |  | $ | 1 |

Other expense remained relatively consistent during the three months and six months ended February 28, 2025, compared to the three months and six months ended February 29, 2024.
Interest Expense, Net

| Three months ended |  |  |  | Six months ended |  |
(in millions) | February 28, 2025 |  | February 29, 2024 |  | Change |  | February 28, 2025 |  | February 29, 2024 |  | Change
Interest expense, net | $ | 37 |  |  | $ | 47 |  |  | $ | (10) |  |  | $ | 75 |  |  | $ | 94 |  |  | $ | (19) |

Interest expense, net decreased during the three months and six months ended February 28, 2025, compared to the three months and six months ended February 29, 2024, due to lower interest rates and lower borrowings primarily on our credit facilities and commercial paper program.
Income Tax Expense

| Three months ended |  |  |  | Six months ended |  |
| February 28, 2025 |  | February 29, 2024 |  | Change |  | February 28, 2025 |  | February 29, 2024 |  | Change
Effective income tax rate | 36.2 | % |  | 12.7 | % |  | 23.5 | % |  | 32.7 | % |  | 13.6 | % |  | 19.1 | %

The effective income tax rate differed for the three months and six months ended February 28, 2025, compared to the three months and six months ended February 29, 2024, primarily due to: (i) a change in the jurisdictional mix of earnings, driven in part by decreased income before income taxes in low tax rate jurisdictions for the three months and six months ended February 28, 2025, (ii) an $18 million income tax benefit for the reversal of an unrecognized tax benefit due to a lapse of statute for the six months ended February 28, 2025, and (iii) the gain from the divestiture of the Mobility Business and corresponding $58 million of income tax expense during the three months ended February 29, 2024.
The Organization for Economic Co-operation and Development (“OECD”) and participating countries continue to work toward the enactment of a 15% global minimum corporate tax rate. Many countries, including countries in which we have tax incentives, have enacted or are in the process of enacting laws based on the OECD’s proposals. We do not currently expect a material impact to our effective tax rate for the fiscal year ending August 31, 2025.
31

Table of Contents
Non-GAAP (Core) Financial Measures
The following discussion and analysis of our financial condition and results of operations include certain non-GAAP financial measures as identified in the reconciliations below. The non-GAAP financial measures disclosed herein do not have standard meaning and may vary from the non-GAAP financial measures used by other companies or how we may calculate those measures in other instances from time to time. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with U.S. GAAP. Among other uses, management uses non-GAAP “core” financial measures to make operating decisions, assess business performance, and as a factor in determining certain employee performance when evaluating incentive compensation. Also, our “core” financial measures should not be construed as an indication by us that our future results will be unaffected by those items that are excluded from our “core” financial measures.
We determine an annual normalized tax rate (“normalized core tax rate”) for the computation of the non-GAAP (core) income tax provision to provide better consistency across reporting periods. In estimating the normalized core tax rate annually, we utilize a full-year financial projection of core earnings that considers the mix of earnings across tax jurisdictions, existing tax positions, and other significant tax matters. We may adjust the normalized core tax rate during the year for material impacts from new tax legislation or material changes to our operations.
Included in the tables below are reconciliations of the non-GAAP financial measures to the most directly comparable U.S. GAAP financial measures as provided in our Condensed Consolidated Financial Statements:
Reconciliation of U.S. GAAP Financial Results to Non-GAAP Measures

| Three months ended |  | Six months ended
(in millions, except for per share data) | February 28, 2025 |  | February 29, 2024 |  | February 28, 2025 |  | February 29, 2024
Operating income (U.S. GAAP) | $ | 245 |  |  | $ | 1,131 |  |  | $ | 442 |  |  | $ | 1,434 |
Amortization of intangibles | 15 |  |  | 9 |  |  | 28 |  |  | 15 |
Stock-based compensation expense and related charges | 21 |  |  | 23 |  |  | 65 |  |  | 69 |
Restructuring, severance and related charges(1) | 45 |  |  | 70 |  |  | 128 |  |  | 197 |
Net periodic benefit cost(2) | — |  |  | 3 |  |  | 1 |  |  | 5 |
Business interruption and impairment charges, net(3) | — |  |  | — |  |  | 9 |  |  | — |
Gain from the divestiture of businesses(4) | — |  |  | (944) |  |  | — |  |  | (944) |
Acquisition and divestiture related charges(4) | 8 |  |  | 46 |  |  | 8 |  |  | 61 |
Adjustments to operating income | 89 |  |  | (793) |  |  | 239 |  |  | (597) |
Core operating income (Non-GAAP) | $ | 334 |  |  | $ | 338 |  |  | $ | 681 |  |  | $ | 837 |
Net income attributable to Jabil Inc. (U.S. GAAP) | $ | 117 |  |  | $ | 927 |  |  | $ | 217 |  |  | $ | 1,121 |
Adjustments to operating income | 89 |  |  | (793) |  |  | 239 |  |  | (597) |
Net periodic benefit cost(2) | — |  |  | (3) |  |  | (1) |  |  | (5) |
Adjustments for taxes(5) | 9 |  |  | 82 |  |  | (12) |  |  | 37 |
Core earnings (Non-GAAP) | $ | 215 |  |  | $ | 213 |  |  | $ | 443 |  |  | $ | 556 |
Diluted earnings per share (U.S. GAAP) | $ | 1.06 |  |  | $ | 7.31 |  |  | $ | 1.93 |  |  | $ | 8.66 |
Diluted core earnings per share (Non-GAAP) | $ | 1.94 |  |  | $ | 1.68 |  |  | $ | 3.94 |  |  | $ | 4.30 |
Diluted weighted average shares outstanding (U.S. GAAP and Non-GAAP) | 111.1 |  |  | 126.9 |  |  | 112.6 |  |  | 129.5 |

(1)Charges recorded during the three months and six months ended February 28, 2025, and February 29, 2024, primarily related to the 2025 Restructuring Plan and 2024 Restructuring Plan, respectively.
(2)We are reclassifying the pension components in other expense to core operating income as we assess operating performance, inclusive of all components of net periodic benefit cost, with the related revenue. There is no impact to core earnings or diluted core earnings per share for this adjustment.
32

Table of Contents
(3)Charges recorded during the six months ended February 28, 2025, relate primarily to costs associated with damage from Hurricanes Helene and Milton, which impacted our operations in St. Petersburg, Florida and Asheville and Hendersonville, North Carolina.
(4)We completed the divestiture of the Mobility Business and recorded a pre-tax gain of $944 million, subject to certain post-closing adjustments that were realized in March 2025. We incurred transaction and disposal costs in connection with the sale of approximately $46 million and $61 million during the three months and six months ended February 29, 2024, respectively.
(5)Tax adjustments for the three months and six months ended February 29, 2024, were partially driven by an income tax expense associated with the divestiture of the Mobility Business.
Adjusted Free Cash Flow

| Six months ended
(in millions) | February 28, 2025 |  | February 29, 2024
Net cash provided by operating activities (U.S. GAAP) | $ | 646 |  |  | $ | 666 |
Acquisition of property, plant and equipment (“PP&E”)(1) | (213) |  |  | (554) |
Proceeds and advances from sale of PP&E(1) | 54 |  |  | 109 |
Adjusted free cash flow (Non-GAAP) | $ | 487 |  |  | $ | 221 |

(1)Certain customers co-invest in PP&E with us. As we acquire PP&E, we recognize the cash payments in acquisition of PP&E. When our customers reimburse us and obtain control, we recognize the cash receipts in proceeds and advances from the sale of PP&E.
Acquisitions and Divestitures
Acquisitions
Fiscal Year 2025
On February 3, 2025, we completed the acquisition of Pharmaceutics International, Inc. (“Pii”) for cash consideration transferred of $307 million. The final purchase price is subject to adjustment based on certain customary conditions as outlined in the purchase agreement. Pii is a contract development and manufacturing organization specializing in early stage, clinical, and commercial volume aseptic filling, lyophilization, and oral solid dose manufacturing. The acquisition will enhance our existing Regulated Industries service offerings, which includes the development and commercial production of auto-injectors, pen injectors, inhalers, and on-body pumps.
The acquisition of Pii was accounted for as a business combination using the acquisition method of accounting. Assets acquired of $349 million, including $149 million in intangible assets and $132 million in goodwill, and liabilities assumed of $42 million were recorded at their estimated fair values as of the acquisition date. The preliminary estimates and measurements are subject to change during the measurement period for assets acquired, liabilities assumed, and tax adjustments. The excess of the purchase price over the fair value of the acquired assets and assumed liabilities was recorded to goodwill and was fully allocated to the Regulated Industries segment. Goodwill is primarily attributable to expected synergies enabling comprehensive support for customers in drug development, clinical trials, and product commercialization at scale. The majority of the goodwill is currently not expected to be deductible for income tax purposes. The results of operations were included in our condensed consolidated financial results beginning on February 3, 2025. Pro forma information has not been provided as the acquisition of Pii is not deemed to be significant.
On October 1, 2024, we completed the acquisition of Mikros Technologies LLC (“Mikros Technologies”) for consideration transferred of $63 million. Mikros Technologies is a leader in the engineering and manufacturing of liquid cooling solutions for thermal management. The final purchase price is subject to adjustment based on certain customary conditions as outlined in the purchase agreement.
The acquisition of Mikros Technologies was accounted for as a business combination using the acquisition method of accounting. Assets acquired of $63 million, including $40 million in intangible assets and $17 million in goodwill, were recorded at their estimated fair values as of the acquisition date. The preliminary estimates and measurements are subject to change during the measurement period for assets acquired, liabilities assumed and tax adjustments. The excess of the purchase price over the fair value of the acquired assets and assumed liabilities was recorded to goodwill and was fully allocated to the Intelligent Infrastructure segment. The majority of the goodwill is currently expected to be deductible for income tax purposes.
33

Table of Contents
The results of operations were included in our condensed consolidated financial results beginning on October 1, 2024. Pro forma information has not been provided as the acquisition of Mikros Technologies is not deemed to be significant.
Fiscal Year 2024
On November 1, 2023, we completed the acquisition of ProcureAbility Inc. (“ProcureAbility”) for approximately $60 million in cash. ProcureAbility is a procurement services provider specializing in technology-enabled advisory, managed services, digital, staffing, and recruiting solutions.
The acquisition of ProcureAbility was accounted for as a business combination using the acquisition method of accounting. Assets acquired of $87 million, including $40 million in intangible assets and $38 million in goodwill, and liabilities assumed of $26 million were recorded at their estimated fair values as of the acquisition date. The excess of the purchase price over the fair value of the acquired assets and assumed liabilities was recorded to goodwill and was fully allocated to the Regulated Industries segment. The majority of the goodwill is currently not expected to be deductible for income tax purposes. The results of operations were included in our condensed consolidated financial results beginning on November 1, 2023. Pro forma information has not been provided as the acquisition of ProcureAbility is not deemed to be significant.
Divestitures
Fiscal Year 2024
We announced on September 26, 2023, that, through our indirect subsidiary, Jabil Circuit (Singapore) Pte. Ltd., a Singapore private limited company (“Singapore Seller”), we agreed to sell to an affiliate of BYD Electronic (International) Co. Ltd., a Hong Kong limited liability company (“Purchaser” or “BYDE”), its product manufacturing business in Chengdu, including its supporting component manufacturing in Wuxi, the Mobility Business, for cash consideration of approximately $2.2 billion, subject to certain customary purchase price adjustments.
As of August 31, 2023, we determined the Mobility Business met the criteria to be classified as held for sale. Assets and liabilities classified as held for sale had a carrying value less than the estimated fair value less cost to sell and, thus, no adjustment to the carrying value of the disposal group was necessary. Depreciation and amortization expense for long-lived assets was not recorded for the period in which these assets were classified as held for sale. The divestiture did not meet the criteria to be reported as discontinued operations, and we continued to report the operating results for the Mobility Business in our Condensed Consolidated Statements of Operations in the DMS segment until the Closing Date.
On December 29, 2023, the Closing Date, we completed the sale of the Mobility Business. As a result of the transaction, we derecognized net assets of approximately $1.2 billion, and recorded a pre-tax gain of $942 million in the fiscal year ended August 31, 2024. Certain post-closing adjustments were realized in March 2025, which will result in recognition of a $54 million pre-tax gain during the three months ended May 31, 2025. In addition, we agreed to indemnify BYDE from certain liabilities that may arise post-close that relate to periods prior to the Closing Date. We incurred transaction and disposal costs in connection with the sale of approximately $67 million during the fiscal year ended August 31, 2024, which are included in continuing operations in our Condensed Consolidated Statements of Operations.
Refer to Note 17 – “Business Acquisitions and Divestitures” to the Condensed Consolidated Financial Statements for discussion.
Liquidity and Capital Resources
We believe that our level of liquidity sources, which includes cash on hand, available borrowings under our revolving credit facilities or future facilities and commercial paper program, additional proceeds available under our global asset-backed securitization program and under our uncommitted trade accounts receivable sale programs, cash flows provided by operating activities and access to the capital markets, will be adequate to fund our capital expenditures, the payment of any declared quarterly dividends, any share repurchases under the approved programs, any potential acquisitions, our working capital requirements and our contractual obligations for the next 12 months and beyond. We continue to assess our capital structure and evaluate the merits of redeploying available cash.
34

Table of Contents
Cash and Cash Equivalents
As of February 28, 2025, we had approximately $1.6 billion in cash and cash equivalents, of which a significant portion was held by our foreign subsidiaries. Most of our foreign cash and cash equivalents as of February 28, 2025, could be repatriated to the United States without potential tax expense.
Notes Payable and Credit Facilities
Following is a summary of principal debt payments and debt issuance for our notes payable and credit facilities:

(in millions) |  |  | 3.950% Senior Notes |  | 3.600% Senior Notes |  | 3.000% Senior Notes |  | 1.700% Senior Notes |  | 4.250% Senior Notes |  | 5.450% Senior Notes |  | Borrowings under revolving credit facilities(1) |  |  |  |  |  | Total notes payable and credit facilities
Balance as of August 31, 2024 |  |  | $ | 498 |  |  | $ | 497 |  |  | $ | 594 |  |  | $ | 499 |  |  | $ | 496 |  |  | $ | 296 |  |  | $ | — |  |  |  |  |  |  | $ | 2,880 |
Borrowings |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 334 |  |  |  |  |  |  | 334 |
Payments |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (334) |  |  |  |  |  |  | (334) |
Other |  |  | — |  |  | — |  |  | 1 |  |  | — |  |  | 1 |  |  | 1 |  |  | — |  |  |  |  |  |  | 3 |
Balance as of February 28, 2025 |  |  | $ | 498 |  |  | $ | 497 |  |  | $ | 595 |  |  | $ | 499 |  |  | $ | 497 |  |  | $ | 297 |  |  | $ | — |  |  |  |  |  |  | $ | 2,883 |
Maturity Date |  |  | Jan 12, 2028 |  | Jan 15, 2030 |  | Jan 15, 2031 |  | Apr 15, 2026 |  | May 15, 2027 |  | Feb 1, 2029 |  | Jan 22, 2026 and Jan 22, 2028 |  |  |  |  |  |
Original Facility/ Maximum Capacity |  |  | $500 million |  | $500 million |  | $600 million |  | $500 million |  | $500 million |  | $300 million |  | $4.0 billion(1) |  |  |  |  |  |

(1)As of February 28, 2025, we had $4.0 billion in available unused borrowing capacity under our revolving credit facilities. The Credit Facility acts as the back-up facility for commercial paper outstanding, if any. We have a borrowing capacity of up to $3.2 billion under our commercial paper program. Commercial paper borrowings with an original maturity of 90 days or less are recorded net within the Condensed Consolidated Statements of Cash Flows, and have been excluded from the table above.
We have a shelf registration statement with the SEC registering the potential sale of an indeterminate amount of debt and equity securities in the future to augment our liquidity and capital resources.
Our Senior Notes and our credit facilities contain various financial and nonfinancial covenants. A violation of these covenants could negatively impact our liquidity by restricting our ability to borrow under the notes payable and credit facilities and potentially causing acceleration of amounts due under these notes payable and credit facilities. As of February 28, 2025, and August 31, 2024, we were in compliance with our debt covenants. Refer to Note 6 – “Notes Payable and Long-Term Debt” to the Condensed Consolidated Financial Statements for further details.
Global Asset-Backed Securitization Program
Certain Jabil entities participating in the global asset-backed securitization program continuously sell designated pools of trade accounts receivable to a special purpose entity, which in turn sells certain of the receivables at a discount to conduits administered by an unaffiliated financial institution on a monthly basis. In addition, a foreign entity participating in the global asset-backed securitization program sells certain receivables at a discount to conduits administered by an unaffiliated financial institution on a daily basis. As these accounts receivable are sold without recourse, we do not retain the associated risks following the transfer of such accounts receivable to the respective financial institutions.
We continue servicing the receivables sold and in exchange receive an immaterial servicing fee under the global asset-backed securitization program. We do not record a servicing asset or liability on the Condensed Consolidated Balance Sheets as we estimate that the fee we receive to service these receivables approximates the fair market compensation to provide the servicing activities.
The special purpose entity in the global asset-backed securitization program is a wholly owned subsidiary of the Company and is included in our Condensed Consolidated Financial Statements. Certain unsold receivables covering up to the maximum amount of net cash proceeds available under the domestic, or U.S., portion of the global asset-backed securitization program are pledged as collateral to the unaffiliated financial institution as of February 28, 2025.
35

Table of Contents
Effective January 23, 2025, the terms of the global asset-backed securitization program were amended to extend the termination date from January 2025 to January 2028. The maximum amount of net cash proceeds available at any one time is $700 million.
In conjunction with our global asset-backed securitization program, we are required to remit amounts collected as a servicer under the global asset-backed securitization program to a special purpose entity, which in turn sells certain receivables to unaffiliated financial institutions that purchased the receivables. The outstanding balance of receivables sold and not yet collected on accounts where we have continuing involvement was approximately $368 million and $338 million as of February 28, 2025, and August 31, 2024, respectively. During the three months and six months ended February 28, 2025, we sold $1.0 billion and $2.0 billion, respectively, of trade accounts receivable, and we received cash proceeds of $1.0 billion and $2.0 billion, respectively. The receivables that were sold were removed from the Condensed Consolidated Balance Sheets and the cash received was included as cash provided by operating activities on the Condensed Consolidated Statements of Cash Flows.
The global asset-backed securitization program requires compliance with several covenants including compliance with the interest ratio and debt to EBITDA ratio of the Credit Facility. As of February 28, 2025, and August 31, 2024, we were in compliance with all covenants under our global asset-backed securitization program. Refer to Note 7 – “Asset-Backed Securitization Program” to the Condensed Consolidated Financial Statements for further details on the program.
Trade Accounts Receivable Sale Programs
Following is a summary of the uncommitted trade accounts receivable sale programs with unaffiliated financial institutions. Under the programs we may elect to sell receivables, and the unaffiliated financial institutions may elect to purchase, at a discount, on an ongoing basis (in millions):

Program |  | Maximum Amount(1)(2) |  |  |  |
A |  | $ | 350 |  |  |  |  |  |
B |  | $ | 100 |  |  |  |  |  |
C |  | 1,900 |  | CNY |  |  |  |
D |  | $ | 230 |  |  |  |  |  |
E |  | $ | 170 |  |  |  |  |  |
F |  | $ | 50 |  |  |  |  |  |
G |  | $ | 100 |  |  |  |  |  |
H |  | $ | 1,200 |  |  |  |  |  |
I |  | $ | 250 |  |  |  |  |  |
J |  | $ | 75 |  |  |  |  |  |

(1)Maximum amount of trade accounts receivable that may be sold under a facility at any one time.
(2)The trade accounts receivable sale programs either expire on various dates through 2028 or do not have expiration dates and may be terminated upon election of the Company or the unaffiliated financial institutions.
In conjunction with our trade accounts receivable sale programs, we are required to remit amounts collected as a servicer under the trade accounts receivable sale programs to the unaffiliated financial institutions that purchased the receivables. The outstanding balance of receivables sold and not yet collected on accounts where we have continuing involvement was approximately $571 million and $367 million as of February 28, 2025, and August 31, 2024, respectively. During the three months and six months ended February 28, 2025, we sold $2.0 billion and $3.7 billion, respectively, of trade accounts receivable under these programs and we received cash proceeds of $2.0 billion and $3.7 billion, respectively. The receivables that were sold were removed from the Condensed Consolidated Balance Sheets and the cash received was included as cash provided by operating activities on the Condensed Consolidated Statements of Cash Flows.
36

Table of Contents
Cash Flows
The following table sets forth selected consolidated cash flow information (in millions):

|  | Six months ended
|  | February 28, 2025 |  | February 29, 2024
Net cash provided by operating activities |  | $ | 646 |  |  | $ | 666 |
Net cash (used in) provided by investing activities |  | (503) |  |  | 1,558 |
Net cash used in financing activities |  | (746) |  |  | (1,455) |
Effect of exchange rate changes on cash and cash equivalents |  | (6) |  |  | (7) |
Net (decrease) increase in cash and cash equivalents |  | $ | (609) |  |  | $ | 762 |

Operating Activities
Net cash provided by operating activities during the six months ended February 28, 2025, was primarily due to non-cash expenses and net income and an increase in accounts payable, accrued expense and other liabilities. Net cash provided by operating activities was partially offset by an increase in accounts receivable, an increase in inventories and an increase in prepaid expenses and other current assets. The increase in accounts payable, accrued expenses and other liabilities is primarily due to the timing of purchases and cash payments. The increase in accounts receivable is primarily driven by the timing of collections. The increase in inventories is primarily to support expected sales levels in the third quarter of fiscal year 2025. The increase in prepaid expenses and other current assets is primarily due to the timing of payments.
Investing Activities
Net cash used in investing activities during the six months ended February 28, 2025, consisted primarily of capital expenditures, principally to support ongoing business in the Regulated Industries, Intelligent Infrastructure, and Connected Living and Digital Commerce segments and the acquisition of Pharmaceutics International, Inc. and Mikros Technologies LLC, partially offset by proceeds and advances from the sale of property, plant and equipment.
Financing Activities
Net cash used in financing activities during the six months ended February 28, 2025, was primarily due to (i) the repurchase of our common stock under our share repurchase authorization, (ii) payments for debt agreements, (iii) treasury stock minimum tax withholding related to vesting of restricted stock, and (iv) dividend payments. Net cash used in financing activities was partially offset by (i) borrowings under debt agreements and (ii) net proceeds from exercise of stock options and issuance of common stock under employee stock purchase plan.
Capital Expenditures
For Fiscal Year 2025, we anticipate our net capital expenditures to be in the range of 1.5% to 2.0% of net revenue. In general, our capital expenditures support ongoing maintenance in our Regulated Industries, Intelligent Infrastructure, and Connected Living and Digital Commerce segments and investments in capabilities and targeted end markets. The amount of actual capital expenditures may be affected by general economic, financial, competitive, legislative, and regulatory factors, among other things.
Dividends and Share Repurchases
We currently expect to continue to declare and pay regular quarterly dividends of an amount similar to our past declarations. However, the declaration and payment of future dividends are discretionary and will be subject to determination by our Board of Directors each quarter following its review of our financial performance and global economic conditions.
37

Table of Contents
We repurchase shares of our common stock under share repurchase programs authorized by our Board of Directors. The following Board approved share repurchase programs were executed through a combination of open market transactions and accelerated share repurchase (“ASR”) agreements (in millions):

| Board Approval Date |  | Amount Authorized |  | Shares Repurchased |  | Total Cash Utilized |  | Remaining Authorization |  | Authorization Completion Date
2022 Share Repurchase Program | Q4 FY 2021 |  | $ | 1,000 |  |  | 16.5 |  | $ | 1,000 |  |  | $ | — |  |  | Q2 FY 2023
2023 Share Repurchase Program | Q1 FY 2023 |  | $ | 1,000 |  |  | 2.7 |  | $ | 224 |  |  | (1) |  | Q4 FY 2023
Amended 2023 Share Repurchase Program(2) | Q1 FY 2024 |  | $ | 2,500 |  |  | 20.4 |  | $ | 2,500 |  |  | $ | — |  |  | Q1 FY 2025
2025 Share Repurchase Program(3) | Q1 FY 2025 |  | $ | 1,000 |  |  | 6.5 |  | $ | 972 |  |  | $ | 28 |  |  |

(1)In September 2023, the Board of Directors amended and increased the 2023 Share Repurchase Program to allow for the repurchase of up to $2.5 billion of our common stock.
(2)In September 2024, an ASR transaction was completed, and 1.0 million additional shares were delivered under the Q4 FY 2024 ASR agreements. As of November 30, 2024, no authorization remained under the amended 2023 Share Repurchase Program.
(3)As of February 28, 2025, 4.3 million shares had been repurchased for $636 million and $364 million remained available under the 2025 Share Repurchase Program. As of April 3, 2025, 6.5 million shares had been repurchased for $972 million and $28 million remains available under the 2025 Share Repurchase Program.
Under ASR agreements, we make payments to the participating financial institutions and receive an initial delivery of shares of common stock. The final number of shares delivered upon settlement of the ASR agreements is determined based on a discount to the volume weighted average price of our common stock during the term of the agreements. At the time the shares are received by the Company, the initial delivery and the final receipt of shares upon settlement of the ASR agreements results in an immediate reduction of the outstanding shares used to calculate the weighted-average common shares outstanding for basic and diluted earnings per share.
The terms of ASR agreements, structured as outlined above, were as follows (in millions, except average price):

Agreement Execution Date |  | Agreement Settlement Date |  | Agreement Amount |  | Initial Shares Delivered |  | Additional Shares Delivered |  | Total Shares Delivered |  | Average Price Paid Per Share |  |
Q1 FY 2024 |  | Q1 FY 2024 |  | $ | 500 |  |  | 3.3 |  | 0.6 |  | 3.9 |  | $ | 128.61 |  |  |
Q4 FY 2024 |  | Q1 FY 2025 |  | $ | 555 |  |  | 4.2 |  | 1.0 |  | 5.2 |  | $ | 107.08 |  |  |
Q2 FY 2025 |  | Q3 FY 2025 | (1) | $ | 310 |  |  | 1.8 |  | 0.2 |  | 2.0 |  | $ | 154.44 |  |  |
Q3 FY 2025 |  | Q4 FY 2025 |  | $ | 309 |  |  | 1.8 |  | (2) |  | (2) |  | $ | 135.99 |  |  |

(1)In December 2024, as part of the 2025 Share Repurchase Program, we entered into ASR agreements to repurchase $310 million, excluding excise tax, of our common stock. Under the ASR agreements, we made payments of $310 million to participating financial institutions and received an initial delivery of shares of common stock. In March 2025, an ASR transaction was completed, and 0.2 million additional shares were delivered under the Q2 FY 2025 ASR agreements.
(2)In March 2025, as part of the 2025 Share Repurchase Program, we entered into ASR agreements to repurchase $309 million, excluding excise tax, of our common stock. Under the ASR agreements, we made payments of $309 million to participating financial institutions and received an initial delivery of shares of common stock. The delivery of any remaining shares will occur at the final settlement of the transactions under the ASR agreements.
In addition, we repurchased shares of its common stock through the open market as follows (in millions):

|  | Three months ended |  | Six months ended
|  | February 28, 2025 |  | February 29, 2024 |  | February 28, 2025 |  | February 29, 2024
|  | Shares |  | Cost |  | Shares |  | Cost |  | Shares |  | Cost |  | Shares |  | Cost
Open market share repurchases(1) |  | 0.7 |  | $ | 94 |  |  | 6.5 |  | $ | 824 |  |  | 2.5 |  | $ | 326 |  |  | 6.5 |  | $ | 824 |

(1)As of April 3, 2025, 2.7 million shares had been repurchased for $353 million through open market transactions under the 2025 Share Repurchase Program.
38

Table of Contents
Warrants
On December 27, 2024, we issued a warrant (the “Warrant”) to Amazon.com NV Investment Holdings LLC (“Warrantholder”) to acquire up to 1,158,539 of our ordinary shares (“Warrant Shares”) at an initial exercise price of $137.7671 per share, which is the preceding 30 trading day VWAP. The Warrant allows for cashless exercise and expires December 27, 2031. The Warrant Shares are subject to vesting for payments for purchased products and services over the seven-year Warrant term, with 59,582 of the Warrant Shares having vested upon issuance.
Upon the consummation of an acquisition transaction (as defined in the Warrant), subject to certain exceptions, the unvested portion of the Warrant will vest in full. So long as the Warrant is unexercised, the Warrant does not entitle the Warrantholder to any voting rights or any other common stockholder rights. The exercise price and the number of Warrant Shares are subject to customary anti-dilution adjustments.
We account for the Warrant as an equity instrument within additional paid-in-capital on the Condensed Consolidated Balance Sheets, and the provision for the warrant is recorded as a reduction to revenue on the Condensed Consolidated Statements of Operations. To determine the fair value of the Warrant, we used the Black-Scholes option pricing model, which is based on assumptions that require management to use judgement. Based on the estimated fair value, we determined the amount of provision for common stock warrant, which is amortized ratably as a reduction to revenue based on our estimate of revenue over the Warrant term.
The fair value of the Warrant was determined as of the issuance date, using the Black-Scholes option pricing model. The following assumptions were used in the model:

| December 27, 2024
Stock price | $ | 145.92
Exercise price | $ | 137.77
Expected life | 7.0 years
Expected volatility(1) | 34.4 | %
Risk-free interest rate | 4.5 | %

(1)The expected volatility was estimated using the historical volatility derived from our common stock.
The following table summarizes the Warrant activity for the six months ended February 28, 2025:

| Warrant Shares
Outstanding as of August 31, 2024 | —
Changes during the period |
Shares granted | 1,158,539
Shares vested | (59,582)
Outstanding as of February 28, 2025 | 1,098,957
Exercisable as of February 28, 2025 | 59,582

Contractual Obligations
As of the date of this report, other than the new operating and finance leases, (see Note 4 – “Leases” to the Condensed Consolidated Financial Statements), there were no material changes outside the ordinary course of business, since August 31, 2024, to our contractual obligations and commitments and the related cash requirements.

Item 3. | Quantitative and Qualitative Disclosures About Market Risk

There have been no material changes in our primary risk exposures or management of market risks from those disclosed in our Annual Report on Form 10-K for the fiscal year ended August 31, 2024.
39

Table of Contents

Item 4. | Controls and Procedures

Evaluation of Disclosure Controls and Procedures
We carried out an evaluation required by Rules 13a-15 and 15d-15 under the Exchange Act (the “Evaluation”), under the supervision and with the participation of our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), of the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15 and 15d-15 under the Exchange Act as of February 28, 2025. Based on the Evaluation, our CEO and CFO concluded that the design and operation of our disclosure controls and procedures were effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in SEC rules and forms and (ii) accumulated and communicated to our senior management, including our CEO and CFO, to allow timely decisions regarding required disclosure.
Changes in Internal Control over Financial Reporting
For our fiscal quarter ended February 28, 2025, we did not identify any modifications to our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
40

Table of Contents
PART II—OTHER INFORMATION

Item 1. | Legal Proceedings

See the discussion in Note 19 - “Commitments and Contingencies” to the Condensed Consolidated Financial Statements.

Item 1A. | Risk Factors

For information regarding risk factors that could affect our business, results of operations, financial condition or future results included in Part I, “Item 1A. Risk Factors” of our Annual Report on Form 10-K for the fiscal year ended August 31, 2024. For further information on our forward-looking statements see Part I of this Quarterly Report on Form 10-Q.

Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds

The following table provides information relating to our repurchase of common stock, excluding excise tax, during the three months ended February 28, 2025:

Period | Total Number of Shares Purchased(1) |  | Average Price Paid per Share |  | Total Number of Shares Purchased as Part of Publicly Announced Program(2) |  | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program (in millions)(2)
December 1, 2024 – December 31, 2024 | 2,514,534 |  |  | $ | 142.54 |  |  | 2,514,534 |  |  | $ | 364 |
January 1, 2025 – January 31, 2025 | 991 |  |  | $ | 169.14 |  |  | — |  |  | $ | 364 |
February 1, 2025 – February 28, 2025 | — |  |  | $ | — |  |  | — |  |  | $ | 364 |
Total | 2,515,525 |  |  | $ | 142.55 |  |  | 2,514,534 |  |  |

(1)The purchases include amounts that are attributable to 991 shares surrendered to us by employees to satisfy, in connection with the vesting of restricted stock unit awards, their tax withholding obligations.
(2)In September 2024, our Board of Directors authorized the repurchase of up to $1.0 billion of our common stock as publicly announced in a press release on September 26, 2024 (the “2025 Share Repurchase Program”). For more information, see “Liquidity and Capital Resources - Dividends and Share Repurchases”.
In December 2024, we issued a warrant to Amazon.com NV Investment Holdings LLC to acquire up to 1,158,539 of our ordinary shares as reported in a Current Report on Form 8-K filed on January 3, 2025. Refer to Note 12 – “Stockholders’ Equity” to the Condensed Consolidated Financial Statements for further details.

Item 3. | Defaults Upon Senior Securities

None.

Item 4. | Mine Safety Disclosures

Not applicable.
41

Table of Contents

Item 5. | Other Information

During the three months ended February 28, 2025, four executive officers adopted trading arrangements intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Securities Exchange Act of 1934.
Rule 10b5-1 trading arrangements:

| Action |  | Date |  | Total Shares to be Sold |  | Expiration Date(1)
Matthew Crowley, Executive Vice President, Global Business Units | Adopt |  | January 30, 2025 |  | Up to 6,012 |  | January 31, 2026
Michael Dastoor, Chief Executive Officer and Director | Adopt |  | January 21, 2025 |  | Up to 28,234 |  | January 10, 2026
Mark T. Mondello, Executive Chairman of the Board of Directors | Adopt |  | December 22, 2024 |  | Up to 630,000 |  | March 31, 2027
Gary K. Schick, Senior Vice President and Chief Human Resources Officer | Adopt |  | January 31, 2025 |  | Up to 4,000 |  | February 28, 2026

(1)Unless earlier terminated pursuant to the terms of the trading arrangement.
No other directors or executive officers of the Company adopted or terminated a trading arrangement intended to satisfy the affirmative defenses of Rule 10b5-1 under the Securities Exchange Act of 1934 or a “non-Rule 10b5-1 trading arrangement,” as defined in Item 408(a) of Regulation S-K, during the three months ended February 28, 2025.
42

Table of Contents

Item 6. | Exhibits

Index to Exhibits

|  |  |  | Incorporated by Reference Herein
Exhibit No. |  | Description |  | Form |  | Exhibit |  | Filing Date/Period End Date
3.1 |  | Registrant’s Certificate of Incorporation, as amended. |  | 10-Q |  | 3.1 |  | 5/31/2017
3.2 |  | Registrant’s Amended and Restated Bylaws. |  | 8-K |  | 3.1 |  | 10/23/2024
4.1 |  | Form of Certificate for Shares of the Registrant’s Common Stock. (P) |  | S-1 |  |  |  | 3/17/1993
4.2 |  | Indenture, dated January 16, 2008, with respect to Senior Debt Securities of the Registrant, between the Registrant and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee. |  | 8-K |  | 4.2 |  | 1/17/2008
4.3 |  | Form of 4.250% Registered Senior Notes due 2027 (included as Exhibit A to the Officers’ Certificate filed herewith as Exhibit 4.9). |  | 8-K |  | 4.1 |  | 5/4/2022
4.4 |  | Form of 5.450% Senior Notes due 2029 (included as Exhibit A to the Officers’ Certificate filed herewith as Exhibit 4.10). |  | 8-K |  | 4.1 |  | 4/13/2023
4.5 |  | Officers’ Certificate, dated as of January 17, 2018, establishing the 3.950% Senior Notes due 2028. |  | 8-K |  | 4.1 |  | 1/17/2018
4.6 |  | Officers’ Certificate, dated as of January 15, 2020, establishing the 3.600% Senior Notes due 2030. |  | 8-K |  | 4.1 |  | 1/15/2020
4.7 |  | Officers’ Certificate, dated as of July 13, 2020, establishing the 3.000% Senior Notes due 2031. |  | 8-K |  | 4.1 |  | 7/13/2020
4.8 |  | Officers’ Certificate, dated as of April 14, 2021, establishing the 1.700% Senior Notes due 2026. |  | 8-K |  | 4.1 |  | 4/14/2021
4.9 |  | Officers’ Certificate, dated as of May 4, 2022, establishing the 4.250% Senior Notes due 2027. |  | 8-K |  | 4.1 |  | 5/4/2022
4.10 |  | Officers’ Certificate, dated as of April 13, 2023, establishing the 5.450% Senior Notes due 2029. |  | 8-K |  | 4.1 |  | 4/13/2023
10.1** |  | Warrant to Purchase Common Stock, dated December 27, 2024, issued to Amazon.com, Inc. |  | 8-K |  | 4.1 |  | 1/3/2025
31.1* |  | Rule 13a-14(a)/15d-14(a) Certification by the Chief Executive Officer. |  |  |  |  |
31.2* |  | Rule 13a-14(a)/15d-14(a) Certification by the Chief Financial Officer. |  |  |  |  |
32.1* |  | Section 1350 Certification by the Chief Executive Officer. |  |  |  |  |
32.2* |  | Section 1350 Certification by the Chief Financial Officer. |  |  |  |  |
101 |  | The following financial information from Jabil’s Quarterly Report on Form 10-Q for the quarterly period ended February 28, 2025, formatted in Inline XBRL: (i) Condensed Consolidated Balance Sheets as of February 28, 2025 and August 31, 2024, (ii) Condensed Consolidated Statements of Operations for the three months and six months ended February 28, 2025 and February 29, 2024, (iii) Condensed Consolidated Statements of Comprehensive Income for the three months and six months ended February 28, 2025 and February 29, 2024, (iv) Condensed Consolidated Statements of Stockholders’ Equity for the three months and six months ended February 28, 2025 and February 29, 2024, (v) Condensed Consolidated Statements of Cash Flows for the six months ended February 28, 2025 and February 29, 2024, and (vi) the Notes to Condensed Consolidated Financial Statements. |  |  |  |  |
104 |  | Cover Page Interactive Data File (Embedded within the inline XBRL Document in Exhibit 101). |  |  |  |  |
* |  | Filed or furnished herewith |  |  |  |  |

43

Table of Contents

** |  | Certain portions of this document have been redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K. Jabil agrees to furnish supplementally an unredacted copy of the exhibit to the Securities and Exchange Commission upon request. |  |  |  |  |

Certain instruments with respect to long-term debt of the Registrant and its consolidated subsidiaries are not filed herewith pursuant to Item 601(b)(4)(iii) of Regulation S-K since the total amount of securities authorized under each such instrument does not exceed 10% of the total assets of the Registrant and its subsidiaries on a consolidated basis. The Registrant agrees to furnish a copy of any such instrument to the Securities and Exchange Commission upon request.
44

Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

| JABIL INC. Registrant
Date: April 8, 2025 | By: | /s/ M ICHAEL D ASTOOR
|  | Michael Dastoor Chief Executive Officer
Date: April 8, 2025 | By: | /s/ G REGORY B. H EBARD
|  | Gregory B. Hebard Chief Financial Officer

45